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Abstract 
 
Understanding the evolution of parasites and hosts following a host-shit event is 
increasingly recognised as being of great importance to public health and the 
clinical/veterinary sciences in predicting the behaviour and evolutionary 
consequences of emerging infectious diseases. Microbial pathogenesis and 
virulence are remarkably complex traits, and only by considering them in the 
context of their hosts can we begin to unravel key questions as to how and why 
disease emerges and persists. The period immediately following a host-shift 
event, where a pathogen circulating in one host species successfully jumps into 
another is critical – whether such outbreak events “burn out” or become 
endemic, and what the ramifications of this might be are difficult to model and 
predict. 
That microbial pathogens and their hosts are in a close coevolutionary 
relationship has been evident since the early days of our understanding of 
disease, but it is only relatively recently that the ecological, molecular, genomic 
and bioinformatic tools all required to understand the subject have become 
widely available and applicable. In the work presented within this thesis, we 
utilise an exceptionally well monitored and studied novel host-pathogen 
interaction – that of the avian bacterial pathogen Mycoplasma gallisepticum and 
its recently infected novel host the House Finch (Haemorhous mexicanus). 
Approximately 25 years ago this pathogen jumped from its established host in 
chickens into the wild passerine finch species, triggering an epidemic which has 
been well monitored from the outset   
We aim to address how host-pathogen coevolution drives particularly the 
evolution of microbial virulence. Our current understanding of such host-
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pathogen interactions within an evolutionary context centres around the 
mathematical and ecological framework of the “Trade-off hypothesis”, but many 
of the assumptions linking pathogen virulence, transmission and replication 
have been difficult to test or to integrate with our modern understanding of how 
microbial virulence is manifested on a molecular level. In exploring these issues 
throughout this text, we consider that this work has progressed our 
understanding in this field and goes some way towards this integration of 
evolutionary theory and more descriptive classical microbiology / molecular 
biology. 
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Chapter 1: Introduction 
 
Understanding the evolution of pathogen virulence and coevolution within host-
pathogen systems is critical to furthering our ability to predict the potential 
development of both endemically circulating and emerging infectious diseases, 
with implications to public health policy and clinical/veterinary sciences. As 
human population growth and demographic changes continue, and the impacts 
of climate change becoming more evident on a global ecological scale, the risk 
of novel emerging infectious diseases (EIDs), particularly from zoonotic sources 
is set to only increase if left unchecked (Petersen et al, 2018). EIDs, for example 
the coronavirus outbreaks of Severe acute respiratory syndrome (SARS) and 
Middle East respiratory syndrome (MERS), and of recent and ongoing ebolavirus 
outbreaks have garnered substantial public interest and concern in recent years, 
highlighting the fact that research into the drivers and ramifications of EID 
emergence will be increasingly of critical importance to public health (Watkins, 
2018). 
Despite the efforts of an extensive research community working across 
myriad host-pathogen systems, key questions remain unanswered and theory 
largely untested in our understanding of disease emergence and evolution, owing 
largely to a scarcity of well-defined research on recent EIDs for which these very 
evolutionary processes have been left to develop in natura without human 
intervention; rightly administered in regards to the fact that those well studied 
pathogens would often have severe public health or commercial ramifications if 
left alone. This fact has meant that finding relevant host-shift and host-pathogen 
systems alone can be complex, with a large focus being confined to laboratory 
phage-bacteria study systems and viral evolution in plants and insects, whilst 
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detailed research concerning of the arguably more complex co-evolutionary 
aspects arising in vertebrate host-pathogen systems has been scarce (Alizon et 
al, 2009). 
Over the course of the work presented herein and going forwards, we aim 
to address the above caveats to our current understanding by using a uniquely 
well-studied vertebrate host-pathogen system, uncomplicated by any intervention 
since its emergence; that of the avian bacterial pathogen Mycoplasma 
gallisepticum and its novel host in the House Finch (Haemorhous mexicanus). As 
shall be elaborated further upon later, some 25 years ago M. gallisepticum 
jumped from its normal host in chickens (Gallus gallus) and into the wild 
passerine Finch species – well studied in it’s own right, where it was quickly 
diagnosed and tracked, with data on its prevalence and severity collected on a 
massive scale. Additionally, bacterial isolates from wild birds collected from the 
outset out of epizootic provide us with an extensive library of experimentally 
valuable samples, which has allowed for the design and execution of experiments 
to study a vertebrate host-pathogen coevolutionary processes at an 
unprecedentedly fine-scale temporal resolution.      
Before, however, we move to a detailed discussion of the system, we 
include here below a brief background concerning the history and current state 
of research in regards to the evolution of virulence and the wider co-evolutionary 
processes in host-pathogen interactions. 
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The evolution of virulence – an introduction to pathogen-host interactions 
and evolutionary theory 
 
Defining Virulence 
Scientific understanding of why pathogens exhibit virulence; i.e. why they cause 
morbidity over the course of an infection and/or often ultimately the death of their 
hosts has been an area of interest from the earliest stages of germ theory 
development, with the concept of differential virulence between strains of newly 
identified pathogens present from the earliest days of its inception (Pasteur et al, 
1881). However, despite this long history of recognition, providing a concrete 
definition of virulence remains surprisingly difficult, with the term used often in 
different contexts or to mean different things depending on the field of research 
and often conflated with the arguably similar term “pathogenicity”. Within the 
fields of clinical microbiology and invertebrate pathology a classical consensus 
stemming primarily from the 1970s emerges, where “pathogenicity” is defined as 
a qualitative ability or potential for an organism to cause disease (often defined 
itself by fulfilment of Koch’s postulates), being applied to broad groups of hosts 
and pathogens, and “virulence” being thusly derived as the quantifiable disease 
causing power of an organism or the degree of pathogenicity exhibited by this 
organism within a narrow host grouping (Aizawa, 1971; Young & Barger, 1971). 
In contrast, within plant pathology these definitions may be more vague, for 
example stating “virulence” to be the relative capacity of an infective agent to 
cause damage in a host (Casadevall & Pirofski, 1999), or even reversed so that 
“virulence” becomes the qualitative term describing where an agent causes 
disease and “pathogenicity” becomes the quantitative measure of such (Bos & 
Parlevliet, 1995). Such distinctions in the definitions of simple terms really do 
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matter in accurately and correctly discussing the subject of virulence and wider, 
the topic of host-pathogen interactions at large. In our case and utilised 
throughout this work we endorse the use of the clinical definition above; that 
pathogenesis is the qualitative ability or potential to cause disease while virulence 
relates to the quantifiable and relative elements of this trait, for example through 
measured mortality rates, or sub-lethal measures such as degree of inflammation 
at a site of infection and/or weight loss in infected hosts. 
 
The avirulence hypothesis and early concepts in the evolutionary biology 
of pathogens 
Early evolutionary theory in regard to pathogen virulence was largely dominated 
by the “avirulence hypothesis”, arising from “the law of declining virulence and 
advancing parasitism” postulated by Theobald Smith at the turn of the 20th 
century (Smith, 1904). Based on his experience as a clinical microbiologist and 
work on “Texas Cattle-fever” (later identified as the apicomplexan Babesia bovis) 
and “rabbit septicaemia bacillus”, Smith theorised that for obligate parasites 
evolution drives a closer and closer association between a pathogen and its host 
leading towards mutualism and an associated loss of virulence over time. Since 
virulence expression leads to host morbidity and mortality, he argued, and these 
in turn would reduce the lifetime transmissibility of a parasite through either host 
death or immune clearance, selection should over time act to reduce virulence 
and thus maximise what we would now term R0, the number of secondary hosts 
infected within a primary hosts infective lifetime, or broadly “transmissibility”. This 
is theory which we now consider defunct and supplanted in large-part by the 
trade-off hypothesis which emerged later on in the latter half of the 20th century 
and which we shall elaborate upon shortly. Hints however to the development of 
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our understanding of pathogen evolution can be found in Smith’s work; although 
his concept of an idealised pathogen tending towards mutualism over time 
appears today to offer little explanation for those which maintain their virulence 
over long-associations with hosts, for example Mycobacterium tuberculosis, and 
is arguably naively optimistic in its projections, in his 1904 paper coining “the law 
of declining virulence and advancing parasitism” Smith writes “… our thesis 
implies in addition to the natural decline of virulence also a gradual rise in 
virulence whenever the resistance of susceptible individuals is raised on a very 
large scale”. He then posits that such increases should occur due to factors which 
increase host-resistance and resistance heterogenicity and variation in host 
populations, namely via incomplete vaccination and population mixing arising 
from host-migration. These predictions are largely in line with some of those 
made by the trade-off hypotheses which came to supplant his work, an interesting 
point in evaluating Smiths theories and an indication perhaps of what theory in 
the field of pathogen evolution would eventually become.  
 
Modern theory – the trade-off hypothesis and paradigm 
Regardless of whether our view of his theory is now oversimplified, Smith’s 
“avirulence hypothesis” stood for most of the 20th century as the commonly 
expressed dogma within the study of pathogen evolution with limited, although 
not non-existent opposition. A primary point of contention which would grow in 
prominence was the implied link between the age of a host-pathogen association 
and its virulence; that old associations should result in avirulence whilst novel 
hosts to a disease would experience much greater mortality and morbidity arising 
from the maladaptation of the parasite. Gordon H. Ball wrote in 1943 an early 
commentary on this point, arguing that the amounting evidence from the ever-
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more accurate taxonomies of various pathogens, and the finding from various 
cross-infection studies using generalist pathogens strongly indicated that this 
idea did not hold to biological reality, particularly referencing some early works 
with avian malarias which had shown low virulence in novel hosts or lasting 
virulence in known long-term associations contrary to the predictions of what had 
come to be termed the “conventional wisdom” (Ball, 1943). 
Along with the rapid progress in molecular biology and genetics over the 
course of the early to mid-20th century, and the coupled development of the 
Modern Synthesis in evolutionary theory, a greater legitimacy and emphasis on 
mathematical modelling in the biological sciences would gain prominence over 
time (Méthot, 2012).  In their seminal works, the two-part “Population biology of 
infectious diseases” by Roy Anderson and Robert May, published in 1979 
(Anderson & May, 1979; May & Anderson, 1979), would apply mathematical logic 
and modelling techniques to address the shortcomings of the avirulence 
hypothesis, in what would come to be termed the “transmission-virulence trade-
off hypothesis” of pathogen evolution (Anderson & May, 1982).  
Central to this idea is virulence is explained as an obligate function of 
pathogen transmission as some degree of host damage or dysregulation by a 
pathogen is maintained by selection in order to optimise transmission of an 
infection from host-to-host. Therefore, virulence is not a fixed trait for pathogens 
but one which is constantly in flux around an equilibrium defined by host-
population structures and susceptibility to infection, including degrees of 
resistance and immune clearance in a much more complex, yet mathematically 
expressible relationship (Anderson & May, 1979; May & Anderson, 1979). This 
schematisation of host-pathogen population dynamics, an example of which is 
14 
 
illustrated below in Fig. 1., has provided a framework in which hypothesis about 
pathogen virulence and transmission dynamics can tested. 
 
Fig. 1. A schematic representing the demographic and biological variables in 
effect for a horizontally transmitted pathogen, where X are susceptible hosts, Y 
are infected hosts and Z are immune hosts and the equilibrium between these 
groups is set by the rate variables a – host birth-rate, b – background mortality 
rate, α - mortality due to infection, v – recovery of hosts from infection, β – 
Transmission rate between infected and susceptible hosts and γ – Loss of 
immunity. Amended from Anderson, R. M., May, R. M., 1979, Population biology 
of infectious diseases: Part I, Nature, 1979, 280 Fig.3. 
 
Through this integrative approach, the trade-off hypothesis provides not only an 
explanation for pathogen virulence in a wider biological context, but also has 
predictive power and suggests mechanistic basis for testing a number of key 
questions in the study of host-pathogen co-evolution of significant importance. 
An important implication of the theory is that it poses questions in relation to 
clinical therapeutics and the rise of drug-resistance, an issue of critical societal 
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importance. Under the trade-off hypothesis, increased host-resistance, and 
subsequently faster pathogen clearance, is suggested to select for faster 
replicating and more virulent strains of the pathogen to evolve over time (Porco 
et al, 2005). Whether naturally occurring through host immune-processes or 
induced via therapeutic treatment of infections, this predicted increase in 
pathogen virulence in response to host-resistance is increasingly well understood 
under the framework of the trade-off hypothesis. When Myxoma virus was 
introduced as a biocontrol agent to control Australian rabbit populations the 
virulence of the introduced strains was found to decrease rapidly at first, only to 
increase again later as a result of evolving host immunity (Best & Kerr, 2000), 
and laboratory experiments conducted under the trade-off framework to test this 
link seem to confirm this assumption; measurements of the evolution of virulence 
in naïve and immunised mice exposed to the murine malaria Plasmodium 
chaubaudii indicated that parasite lines evolved in immune hosts ultimately 
produced higher parasitaemia infections than those evolved in mice more 
susceptible to infection (MacKinnon & Read, 2004). This latter experiment also 
exemplifies a key assumption made in the study of pathogen evolution in 
measuring parasitaemia as a proxy of virulence – that pathogen replication rate 
and virulence are proportional, with more pathogen replication resulting in greater 
host-exploitation and damage.       
 
3 – Evolution and Mechanisms of Microbial Virulence 
 
Virulence manifests as a proportional effect of Pathogen replication 
Although the trade-off hypothesis offers an explanation for why virulence 
emerges – i.e. depending on transmission dynamics some host exploitation is 
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strictly required by a parasite, with subsequent damage and dysregulation 
manifesting as observed pathogen virulence, this does not by itself explain why 
virulence varies between parasite lineages and, although it posits an “optimal 
virulence” maxima where transmission is maximised this alone does not describe 
adequately what evolutionary processes drive virulence towards this optimal 
value. It has long been observed that pathogens in serial passage in vivo often 
gain in virulence (Ebert, 1998), suggesting that this selection cannot only occur 
in response to host-immunity. Developing theory on these processes requires an 
understanding of the multi-hierarchical nature of selection occurring in the multi-
stage and often complex life cycles of successful pathogens; i.e. that there is not 
only between-host selection, where high fitness corresponds to the most 
transmissible lineages, but also within-host selection where pathogen lineages 
will compete within a single infection.   
If we consider that in nature, even for a single pathogen species, infections 
are not commonly caused by a single infective cell or particle but rather an 
inoculum population containing multiple parasite lineages, then the basis for this 
becomes clear. In order to maximise fitness on an inter-host level a single 
parasite lineage must come to dominate the transmissible population of different 
parasite lineages over the course of an infection (Bose et al, 2016). Since the 
most obvious way to do this is to outnumber the competition within-host, selection 
on this level should in theory act to increase replication rates up to a point. Thus, 
if faster replication is selected for, and is coupled to host-exploitation, virulence 
subsequently increases. Of note, even if a truly clonal parasite is used to infect a 
host with just one parasite lineage, given the rapid generation time of most 
pathogens in an infection both neutral and diversifying selection processes 
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generate standing variation within the population (Didelot et al, 2016) on which 
this selection for increased replication rate could occur.   
 
Social Theory and pathogen evolution 
At this point, having considered how selection for faster replication may occur 
within a host we lead naturally into a brief discussion of social-theory in microbial 
evolution. This burgeoning field aims to investigate how interactions between 
microbes effects their behaviour through both co-operative and antagonistic 
processes and how such this leads to community structure, as well as it’s 
implications for evolutionary processes in such conditions. In regard to pathogen 
virulence these theories suggest a role to play for not only inter-specific microbial 
interactions, for example between invading pathogens and host microbiota 
(Bäumler et al, 2016; Koskella et al, 2017), but also makes predictions for the 
kind of intra-specific selection that might occur over the course of a single 
infection. A great array of microbes have evolved quorum sensing apparatus – 
typically two-component sensory systems, to enable them to detect the 
community composition of other microbes around them, and for pathogens this 
can be employed to better survive and proliferate within infected hosts (West et 
al, 2007). Many of the molecular effectors of virulence, discussed later in this 
chapter, can be classed as “public goods”, in the sense that their production 
benefits not only the source bacteria but also those around it. Siderophore 
production for example helps sequester free iron away from the host and makes 
it available to pathogens as a cofactor in their growth, but are secreted and, 
operating outside of the cell which produced them provide a more dispersed 
benefit to cells over a larger area. Because of this, evolutionary strategies like 
“cheating”, where a cell produces no public good effectors themselves but gains 
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the benefit of those around them have evolved, and in order to minimise the 
amount of these “cheaters”, many microbes have evolved counterstrategies, for 
example regulating their production of these virulence factors based upon their 
surrounding community composition and evolving higher specificity to effectors 
so that only highly-related neighbours will benefit (Meyer et al, 1997; Griffin et al, 
2004; Smith et al, 2005). 
 Although the networks of co-operative and antagonistic behaviours 
between microbes highlighted by social theory can be complex, we can derive 
from it many hypotheses relevant to studying the evolution of pathogen virulence. 
Notably, much recent research has shown that relatedness between bacteria can 
impact virulence and its evolutionary trajectory. For Pseudomonas aeruginosa 
and Staphylococcus aureus, quorum sensing enables cooperation between 
closely related bacteria and leads to greater host-exploitation and virulence 
(Rumbaugh et al, 2009; Pollitt et al, 2014). The exact relationship between 
relatedness and virulence however is likely subject to the particulars of 
community composition, scale, and the type of interactions which occur between 
microbes (West et al, 2007; Buckling et al, 2008)    
 
The role of host-resistance in increasing pathogen replication rate 
Complicating the picture discussed above of intra-host competition between 
lineages is the issue of host immunology and resistance. Since infection with 
parasites, particularly those which manifest severe virulence, incurs a fitness cost 
to hosts there is in novel host-pathogen interactions a tendency for host 
resistance to quickly co-evolve along with pathogen virulence. Typically, this will 
result in faster immune clearance of the pathogen, shortening infection times and 
reducing the window for onwards transmission of the parasite. Along with the 
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selection pressure to increase pathogen replication rates arising from the 
stochastic intra-host competition mentioned above, the effect of host-resistance 
is expected to compound further upon this effect to some extent but is also a 
perhaps more complex relationship than is obvious. Host-resistance or immunity, 
in increasing rates of clearance and shortening the duration of infection may 
select for pathogen lineages which are capable of faster replicating to a 
transmissible level and also causing the necessary virulence manifestation to 
transmission to occur depending on its route. However, pathogens lineages 
which are too virulent are also more likely to be cleared by the increased host 
immune processes under these models, and this would result in a selective 
pressure favouring parasite lineages of intermediate virulence in response to 
host-resistance (Antia, 1994). 
Although this above point presents some conveniently testable 
hypotheses in linking virulence to pathogen replication and host-resistance, 
developments from the large body of work building on the Transmission-virulence 
trade-off model continues to challenge the underlying assumptions presented 
therein. In regard to the effect of host-resistance, it has become clear from both 
modelling and empirical approaches that, far from being an easily parameterised 
variable, resistance is in fact a complex and multi-facetted trait. Firstly, we should 
consider that resistance, in an otherwise viable host-pathogen interaction, arises 
from often complex host immunological-processes which can vary both between 
individuals and within individuals based on life-history (reviewed in Ashley et al, 
2012). Ageing, for example, appears to play a role in the behaviour of innate 
immune processes; as infection history develops and cell damage mount over a 
hosts lifespan, the expression of innate immune pathogen recognition ligands 
and other innate-immunity signalling genes can increase, resulting in in-turn 
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higher levels of pro-inflammatory molecules and higher inflammatory responses 
in aged hosts compared to younger individuals (Shaw et al, 2013). On shorter 
timescales, seasonal conditions can produce similar heterogenicity in host 
immune-responses – for example, pro-inflammatory cytokines are 
downregulated in responses to LPS during simulated shorter days lengths (i.e. 
simulating winter conditions) in Siberian hamsters, alongside more general 
changes in host sickness behaviours, and these are thought to be associated 
with the changing fitness costs to mounting immune-responses as energy 
requirements and resource availability vary in the wider ecological context (Bilbo 
et al, 2002). That immune-system activity – and subsequently host-resistance to 
pathogens, might not be a constant parameter as formulated by a simple model 
of the trade-off hypothesis presents significant challenges to its applicability in 
understanding pathogen-evolution without some modification. If as stated above, 
resistance should select for faster-replicating and thus more virulent pathogen 
strains up to a value optimal for onwards transmission, then the shifting patterns 
of host immune activity and its subsequent effectiveness in clearing pathogens 
could have large implications in the strength or direction of such selection.  
A key modification to the trade-off hypothesis which has been made in 
redress to these shortcomings is to integrate it with the concept of 
immunopathology (Graham et al, 2005; Day et al, 2007; Long et al, 2011), which 
goes some way to include the energetic and physiological costs of resistance, 
and how these might impact host-pathogen coevolution. Reasoning that virulence 
for many infections is not driven solely by pathogen elements, but also manifests 
from self-damage caused by host immune-processes allows for consideration of 
how the relative damage of an infection caused either directly by a pathogen or 
indirectly by the host response can alter the fitness parameters of virulence 
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evolution. A mathematical approach to this delineates host immune-responses to 
infection into those which cause either an independent immunopathology, i.e. 
self-damage not scaling to pathogen resource exploitation, or a proportional 
immunopathology, and posits that this can have drastically different effects on 
the evolution of pathogen virulence. Such models predict that when independent 
immunopathology causes high host-mortality – for example characteristically for 
influenza (Xu et al, 2004), selection should favour more exploitative, and thus 
virulent pathogen strains, since lessening exploitation would have little effect on 
lowering mortality and thus extending the time-frame for transmission. 
Conversely, where immunopathology scales to pathogen exploitation, pathogen 
transmissibility and fitness can be increased by lowing directly pathogen-driven 
virulence effecting host-mortality, leading to selection for less exploitation as a 
mechanism to reduce host immune activation and immunopathology driven 
mortality (Day et al, 2007). 
 
Tolerance – further complicating the picture of host-defences to infection      
Related to the above concept of immunopathology, it is important to consider 
further that host defensive responses to infection can be broadly defined into the 
two broad categories of resistance and tolerance. From an evolutionary 
standpoint, hosts can adopt two strategies for dealing with infection. Resistance 
relates to those mechanisms which directly combat pathogens by either blocking 
infection and providing some degree of protective-immunity, e.g. by genetic 
mutation of receptors required for pathogen colonisation/invasion, or by 
facilitating faster clearance of pathogen by altering the specificity of immune-
responses; the effect  of either mechanism being to lower pathogen loads in a 
resistant host compared to one with no evolved resistance. Alternatively, 
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mechanisms of tolerance can evolve, where pathogen load is unaffected but 
immunopathology and thus an infections manifest virulence, is reduced 
(Schneider et al, 2008; Medzhitov et al, 2012).  Importantly, the relationship 
between tolerance and resistance evolution is likely distinct depending on the 
exact mechanistic basis at play, with these mechanisms possible trading off 
against one another in effect. They can be intrinsically linked and antagonistic to 
each other, for example in the production of microbe killing reactive oxygen 
species by phagocytic cells in the innate immune response, which provide 
resistance to pathogens by increasing rates of clearance but incur large 
immunopathological costs though oxidative stress (Lambeth et al, 2007a; 
Lambeth et al, 2007b) and thus reduce tolerance. Alternatively, tolerance 
mechanisms can exist which act largely independently of resistance, for example 
through systemic changes in host-metabolism or the increased expression of 
host-repair genes (Schneider et al, 2008). The potentially huge complexity of this 
aside, the point of this remains that both resistance and tolerance are capable of 
influencing the evolutionary trajectory of pathogens, though with perhaps different 
effects, through their integration into such models which include 
immunopathological parameters, and are as such vital to our understanding of 
virulence evolution.    
It is thus evident that the relationship between virulence, pathogen 
replication, transmission and host resistance is clearly a complex one, likely to 
vary depending on the exact biology of the species involved. Furthermore, 
although evolutionarily perhaps the most intuitive driver of virulence, microbial 
virulence is clearly a multifaceted trait with numerous causes which cannot simply 
be explained by this linkage to pathogen replication. In the following section we 
address some of the molecular mechanisms which affect virulence upon an 
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infected host, whether that is dependent and strictly proportional to pathogen load 
or not. 
 
Virulence Factors and the Damage-Response framework of microbial 
pathogenesis and virulence 
From a clinical and descriptive microbiology perspective, much of the host-
damage manifested by infecting pathogens occurs via the molecular effects of 
what is loosely termed “virulence-factors”. This umbrella term defines a myriad of 
compounds, proteins and other pathogen components and traits which act as 
effectors of damaging host-responses, often acting to subvert host-resistance 
and immunological mechanisms to the pathogens benefit. These individual 
virulence factor components can have multiple functions within an infection, 
varying between hosts and even sites of infection, and encompass a field of study 
far too vast to detail in anything nearing completion; however, for our purposes a 
brief overview given here with some defining concepts and important examples 
should suffice. 
Largely an artefact of the historical argument that microorganisms 
exhibiting pathogenicity, i.e. “pathogens”, must have some intrinsic qualitative 
difference to environmental or commensal microbes, defining what is and what 
isn’t a virulence factor has proven to be a complicated issue. Since many 
pathogens are now known to be opportunistic, or to only exhibit pathogenic 
behaviour under certain conditions, the line between pathogenic and non-
pathogenic microorganisms has been significantly blurred. A modern concept 
which has recently developed to address these issues and provide a framework 
in which to discuss virulence-factors is that of the “Damage-Response” 
framework of microbial pathogenesis (Casadevall & Pirofski, 2003). Rather than 
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focusing entirely on the biology of the microorganism, this approach considers 
instead that virulence factors are defined from the interactions of specific 
microbial components with host-factors and responses and allows for the 
contextualisation of pathogenesis and virulence on both an organismal and 
molecular level. Under this framework individual microbial species and strains 
can be associated with a given damage-response curve in a host species (fig. 2 
below); an expression of how its virulence manifests under different host-
response strengths.  
 
 
Fig. 2 : A) A damage-response plot for a typical pathogen – virulence is limited at 
intermediate host-responses, but where host responses are either weak (e.g. in 
immunocompromised hosts) or strong (e.g. in immune over-activation) virulence 
causes increased morbidity and mortality. B) The damage-response curve of a 
microbe which causes disease only in context of weak or overly strong host-
responses but is otherwise beneficial. This curve might relate best to commensal 
gut microbiota, which when kept in check by normal host-responses contributes 
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to host-health. Amended from Casadevall, A., Pirofski, L., 2003, The Damage-
Response Framework of Microbial Pathogenesis, Nature Reviews Microbiology, 
2003, 17, Fig.1. and Fig.2.C 
 
Applying this concept to host-pathogen interactions, a virulence factor becomes 
defined as any microbial behaviour or component which biases the host-
response variable to induce greater virulence, and this approach resolves some 
of the issues of defining virulence factors otherwise (Casadevall & Pirofski, 2009). 
For example, bacterial endotoxin is a classic virulence-factor, but is also an often-
essential membrane component of bacteria which may or may not exhibit 
pathogenic behaviours; the damage-response framework allows it to be regarded 
as a virulence-factor under specific circumstances as an infective agent within 
the context of a host response, but not, for example when the microbe exists in a 
free-living environmental state. This idea can also be reasonably extended to 
encompass a more fine-detail exploration of how and why virulence is manifested 
in an evolutionary context. In the case of virulence selection mediated by 
replication rates detailed above it becomes arguable that for example a mutation 
in one of a microbes DNA-replication machinery genes, or some other which 
increases the efficiency of host resource exploitation and thereby increases the 
speed or frequency of replication becomes a virulence-factor, whereas its wild-
type or the population norm variant of a gene is not. Within this context, the 
definition of virulence as the relative damage or harm caused to the host, with 
emphasis on the word “relative”, combined with the quantisation of how we can 
contextually define a virulence-factor goes some way to combine the evolutionary 
and molecular aspects of our understanding of the subject.  
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We have spent some time here on this discussion of the damage-response 
framework because, in the authors opinion, this provides perhaps the best way 
forwards with which to understand the mechanistic basis of  pathogen virulence 
traits of particular importance to this thesis; that of replication rates as discussed 
above, microbial immunomodulation and immunoevasive strategies, and the 
capacity of microbes to form biofilms and their architectural determinants of 
virulence, to be reviewed briefly below. 
 
Microbial Immunomodulation of hosts 
Microbial pathogens have evolved many strategies in order to both evade host 
immune processes and to co-opt them to further their infective lifecycles. The 
immunomodulatory capabilities of microbial pathogens are diverse and can target 
both humoral and cell-dependant immunity, as well as many facets of the innate 
immune system, as we shall now discuss in brief. 
On encountering an infective agent, “acute-phase” innate immunity is the 
first line of defence for susceptible hosts, beginning with the non-specific 
recognition of non-self cells or particles and occurring concurrently with the initial 
infection and colonisation of the pathogen. At this stage, interactions between 
microbes and host cells are primarily based on those occurring between the 
immediately visible cell (or capsid/envelope in the case of viruses) surface 
components of the pathogen and host cells and other secreted host immune 
effectors. As part of the normal innate-response which evolved early in Metazoa 
(Buchmann, 2014), these pathogen surface Pathogen-associated molecular 
pattern (PAMP) molecules can be recognised by host cell membrane proteins, 
broadly termed Pattern Recognition Receptors (PRRs), for example the 
recognition of Gram-negative bacterial lipopolysaccharide by host Toll-like 
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receptor 4 and CD14 PRRs (Zanoni et al, 2011), leading to phagocytosis of the 
bacteria. Simultaneously opsonisation, where PAMPS interact with secreted 
innate immunity effectors of the complement system may occur, enhancing their 
recognition by host cellular defences or directly killing parasite cells through lysis 
and the complement cascade (Gasque, 2004).   
Ideally from the host immune perspective this results in either direct killing 
of pathogens or phagocytosis and endosomal destruction of the infective agent 
before an serious infection can be established, with a wider immune response to 
the infection induced via a complex network of cell-to-cell and cytokine signalling 
pathways. At the same time however, pathogenic microbes can employ a huge 
variety of means to evade or hijack these processes.  
 
Immunoevasion 
Staphylococcus aureus is a particularly notable human pathogen which exhibits 
significant immunoevasive capabilities against host immune processes, 
possessing a variety of genes encoding virulence factors for this purpose (Foster, 
2005). Staphylococcal complement inhibitor (SCIN) is an early expressed and 
secreted protein which binds to C3 convertase, an integrating part of the 
complement cascade, blocking opsonisation of the bacteria and inhibiting its 
complement mediated cell-lysis and phagocytosis. Similarly, Chemotaxis 
inhibitory protein of staphylococci (CHIPS), also expressed early on by the 
bacteria, acts to affect downstream signalling from activated immune cells and 
inhibit neutrophil chemotaxis towards sites of infection (Rooijakkers et al, 2006). 
The effect of these for S. aureus is to generally inhibit the host pro-inflammatory 
response and dampen immune responses to the site of infection in general, a 
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predominately immunoevasive strategy; but this is not always the case for all 
immunomodulating pathogens.  
 
Immunomodulation and the Induction of Pro-inflammatory Signalling 
In discussing the induction of pro-inflammatory processes, a useful example can 
be found in recent work on Staphylococcus epidermidis which also goes to 
exemplify the contextual nature of virulence depending on host biology and 
infection site. S. epidermidis is typically regarded as a commensal and normal 
part of the human skin microbiota (Grice et al, 2009), but can cause disease in 
the immunocompromised (Blum & Rodvold, 1987) and is the leading cause of 
late-onset neonatal sepsis (Dong et al, 2015). In such cases infection with S. 
epidermidis becomes particularly invasive within the respiratory and pulmonary 
systems of susceptible hosts where the bacteria bias the host-response to 
promote signalling of pro-inflammatory cytokines. Expression of pro-inflammatory 
inducing virulence factors by S. epidermidis such as cytolytic phenol-soluble 
modulins (PSMs) (Cheung et al, 2014) cause upregulation of host TNF-α, IL-6 
and IL-8, as well as chemoattractants which lead to a runaway inflammatory 
response and subsequently high virulence expression in these tissues (Dong et 
al, 2019).  PSMs as virulence factors are themselves interesting in the regards 
that they appear to have originated as part of the commensal colonisation of S. 
epidermidis as a non-pathogenic skin microbiota being involved in biofilm 
formation on epidermal surfaces, only evolving to contribute to invasiveness and 
pathogenesis later (Cheung et al, 2014), again highlighting the complexity of 
defining microbial virulence-factors in isolation. 
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Biofilm formation and the importance of infection architecture in disease 
The above example of S. epidermidis also hints at the role played by the physical 
state and microenvironment which pathogens exist in over the course of infection. 
For our work, the capability of microbes to form biofilm structures is an important 
area of investigation. Many, if not most bacteria in the environment (Dunne, 2002) 
and within the context of infections (Segura et al, 2016) live in this sessile form 
as a part of biofilms, and this appears to have major, though not clear-cut 
implications for microbial pathogenesis and virulence. As with the staphylococcal 
examples discussed above, biofilm formation has been linked to virulence for 
many pathogens, particularly those causing persistent infections (Costerton et al, 
1999). Biofilm production creates static sites of microbial growth, where either 
commensal or pathogenic microbes can live within structured multi-species 
communities or as mono-culture populations, and effect many of the dynamics 
between microbes and hosts. Consisting of a complex extracellular matrix of 
secreted polysaccharide, proteins and nucleic acids, biofilms appear to be major 
modulators of host-responses during infection but determining the virulence-
factor mechanisms and basis of this has remained challenging; whether biofilm 
production enhances or inhibits virulence seems to vary on a case to case basis. 
For Pseudomonas aeruginosa biofilms are strongly linked to increased virulence 
and persistence in cystic fibrosis patients, where it is a noted and severe 
opportunistic pathogen (Phillips & Schultz, 2012), whereas for Streptococcus suis 
infecting pigs it appears to bias infections towards low-virulence commensalism 
(Vötsch et al, 2018). This apparent variability in the function of biofilms as relates 
to microbial virulence is clearly an important area of study if we are to understand 
the biology of individual pathogens and may arise as a consequence of complex 
evolutionary processes which can only be adequately understood by considering 
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such structures. Previous work indicates that the structural and environmental 
heterogeneity of biofilms can create complex diversifying selection processes in 
such structures, as illustrated in Fig. 3 below. Changing exposure to host immune 
factors and nutrients along the diffusive gradients generated within biofilms can 
affect microbial replication and the expression of virulence factors, and as 
populations stratify along these gradients selection pressures are expected to 
change substantially (Steenackers et al, 2016). 
 
Fig. 3. Population stratification and microenvironmental variation in biofilms 
allows for greater diversification and maintenance of diverse lineages/genotypes 
within a microbial population. Different colours represent new lineages arising 
from radiation of starting lineages in either planktonic or biofilm forming cultures. 
Amended from Martin, M., Hölscher, T., Dragoš, A., Cooper, V. S., Kovács, A. T., 
2016, Laboratory Evolution of Microbial Interactions in Bacterial Biofilms, Journal 
of Bacteriology, 2016, 198; 19 
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The examples given above of microbial virulence-factors and determinants are, 
as mentioned, only scratching the surface of the rich and complex ways in which 
microbes interact with their hosts and host-environments over the course of an 
infection and affect each other through hard to predict co-evolutionary processes 
which require often-difficult experimental approaches to adequately study and 
address in any detail. In our study system of the M. gallisepticum – House finch’s 
epizootic we are able to begin to address many issues concerning co-evolution; 
due to the recent nature of this host-shift and novel-interaction, many of the 
complexities of this relationship are simplified in that the confounding effects from 
unobserved and unmeasured long-term host-pathogen co-evolution are here 
absent, giving us an unparalleled opportunity to study host-pathogen co-evolution 
in a wild vertebrate host. Below, we detail a little of the evolutionary history and 
pathogenesis of Mycoplasmas in general and a brief history of the House finch, 
leading into a more in-depth discussion of the system at large. 
 
4 – Background of the M. gallisepticum and H. mexicanus host-pathogen 
system 
 
Mycoplasma  
Mycoplasma spp. belong to a diverse genus of Mollicutes class bacteria and are 
amongst the smallest known prokaryotes in terms of both physical size and 
genomic content (Maniloff, 1983), with typical cell-diameters of around 0.3µm and 
genomes ranging from only around 600-1700 kilobases (Razin, 1992). Although 
modern phylogeny of the taxa suggests an origin for the clade within the Gram-
positive bacteria (Thomson et al, 2011), they are considerably dissimilar from the 
typical structural form of this grouping as well as from the Gram-negative bacteria, 
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lacking entirely a defined cell wall with neither typically prominent peptidoglycan 
or lipopolysaccharide components and instead possessing a lipid-bilayer 
membrane with associated lipoproteins (Razin, 1992), in many ways resembling 
that of typical eukaryotic membrane architectures. By this interesting confluence 
it should perhaps therefore be unsurprising that by-and-large members of this 
genus are found in close association as either as parasites or symbiotes of 
eukaryotes; in fact they appear to be near-ubiquitous across the Metazoa, found 
in a great number of host-species (Sumithra et al, 2013), and have even 
differentiated within individual hosts down to the level of specific tissue-trophisms 
– notably between species, for example M. pneumoniae and M. genitalium 
infecting Homo sapiens, but even down to the within species strain-level in some 
Mycoplasma spp.(Kleven et al, 1975). This unusual physiology and wider ecology 
of Mycoplasmas has since interested microbiologists and clinicians from the 
discovery of the microorganisms.  
First identified at the end of the 19th C. as the aetiological microbe causing 
bovine peripneumonia (Nocard et al, 1898), but misclassified as a fungal infection 
at the time due to its atypical appearance, Mycoplasmas are commonly 
associated with disease and, despite a paucity of identifiable “classical” toxins, 
appear to possess complex immunomodulatory and immunoevasive capabilities 
though the actions of various lipoproteins and their derivatives (Chopra-
Dewasthaly et al, 2017; Saeki et al, 2018, but see Christodoulides et al, 2018 for 
a recent in-depth review). For example, in Mycoplasma gallisepticum and other 
Mycoplasmas infecting poultry antigenic variation caused by the expression of 
variable length haemagglutinin pMGA / VhlA adhesins by the bacteria mask these 
major surface epitopes to help to avoid immune detection and clearance and to 
promote colonisation and cell-invasion by the bacteria (Benčina et al, 2001, 
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Pflaum et al. 2018). Upon successful establishment of an infection, Mycoplasmas 
then cause pathogenic and cytotoxic damage to their hosts through further action 
of the immunomodulatory lipoproteins and lipopeptides discussed above, and 
directly from the production of hydrogen peroxide and superoxide radicals 
generated during bacterial metabolism and growth (Parrott et al, 2016). The 
inflammation caused by these processes then aid in the transmission of the most 
well-studied Mycoplasmas – for example in M. pneumoniae by aerosolisation of 
the bacteria caused by coughing and sneezing (Brown et al, 2016), or by causing 
conjunctivitis and fomite deposition of the bacteria in M. gallisepticum infecting 
birds (Dhondt et al, 2007).  
M. gallisepticum is of particular interest as the focus of a large part of this 
body of work. One of several Mycoplasma spp. found in poultry – particularly 
infecting chickens and turkeys, M. gallisepticum causes chronic respiratory 
disease and sinusitis in these respective hosts, with other symptoms including 
coughing, sneezing and nasal discharge and, notably, conjunctivitis in chickens 
(although the latter is considered a minor clinical indicator), with potentially 
severe and commercially important effects on weight, growth and egg-laying as 
well as relatively high mortalities of up to 30% in complex outbreaks (Stripkovits 
et al, 1996). Transmission occurs either horizontally between birds through direct 
contact or via fomites, or vertically, at least in chickens, via invasion through 
infected tissues into the oviduct and subsequently ova (Levisohn et al, 2000). 
Despite the observed virulence of M. gallisepticum, in many cases infections are 
seen to be sub-clinical or asymptomatic, with the continued circulation of disease 
attributed to mycoplasma’s immunoevasive capabilities, e.g. though antigenic-
variation of immunodominant lipoproteins (Bencina, 2002), and as for many other 
pathogenic Mycoplasma spp., the apparent ability to form biofilms (Feng et al, 
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2018; Raymond et al, 2018, McAuliffe et al, 2006), enabling more long-term 
chronic infections in some cases rather than the typically observed acute 
respiratory disease (Chen et al, 2012). 
The molecular biology of M. gallisepticum pathogenesis having been 
touched upon briefly above and will further explored throughout the text, but a 
comprehensive review of Mycoplasma virulence is beyond the scope of this 
introduction and indeed still a rich vein of research across evolutionary, clinical 
and veterinary sciences. Suffice to say, as with the other Mycoplasmas 
associated with disease, the mechanisms by which M. gallisepticum manifests 
pathology are diverse, complex and often unique to the genera.  
The House Finch (Haemorhous mexicanus) 
The House Finch is a small, brightly coloured songbird found throughout N. 
American ranges through the continental United States and Mexico. Native to the 
southwestern US and Mexican Sonoran Desert biomes, the species has an 
interesting story itself and has been utilised as a model organism for studies in 
population genetics (Wang et al, 2003), as well as for understanding colouration, 
signalling and stress responses in birds (Hill et al, 1994, McGraw et al, 2000). 
With males displaying attractive vibrant red and yellow colouration, individuals 
were commonly traded as pets for much of the 19th and 20th centuries, 
transplanting the species from its native range to locations throughout the east 
coast of America and Hawaii. In 1940 federal protection of the species made this 
trade illegal, and the subsequent release of individuals from dealers in Long 
Island, New York resulted in the establishment of the first eastern U.S. 
populations of House finches (Aldrich et al, 1978). Spreading rapidly throughout 
this new range and supplanting a number of other species within its ecological 
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niche (Wootton, 1987), the House finch soon became a familiar site at bird-
feeders throughout the country. As such, the geographical spread and monitoring 
of Haemorhous mexicanus has yielded a great deal of data through citizen 
science projects such as the Cornell Lab of Ornithology associated Project 
Feederwatch  (www.feederwatch.org) on the species behaviour and ecology, and 
this has facilitated it’s use as a model organism in the aforementioned fields. 
The M. gallisepticum – House Finch Epidemic 
As populations of H. mexicanus continued to grow within this eastern-range, 
more and more contact between wild House finches and commercial and 
domesticated species would be expected and subsequently the risk of a disease 
spill over from one into the other more likely. In the U.S. state of Maryland c.1994 
this pathogen host-shift event did indeed occur, with M. gallisepticum making the 
jump from commercial broiler chicken flocks into the previously uninfected House 
finch (Lay et al, 1996, Dhondt et al, 1998, Delaney et al, 2012) , Fig. 4.. Although 
a number of studies have identified that all circulating House finch M. 
gallisepticum isolates appear to be descended from a single common ancestor 
(Tulman et al, 2012; Delaney et al, 2012), the low competency of chicken-derived 
isolates subsequently measured in house finches suggests some pre-adaptive 
mutation of M. gallisepticum circulating in chicken hosts to have predisposed the 
host-shift to occur, indicating that the event cannot just be due to greater contact 
between host-species alone (Staley et al, 2018)..  
 
36 
 
 
Fig. 4. (Left Panel): H. mexicanus (House Finch) exhibiting severe symptoms 
of mycoplasmal conjunctivitis. (Right Panel): Healthy house finch. Copyright 
Hill, G. E., amended from Bonneaud et al, 2011) 
 
 
 
 
Causing severe conjunctivitis and upper respiratory tract infections and proving 
highly virulent and contagious within this novel host, M. gallisepticum spread 
rapidly throughout the eastern House finch population, causing a precipitous 
decline in the number of birds recorded and mortality estimated to be in the tens 
to hundreds of millions of individuals (Nolan et al, 1998, Hochachka et al, 2000). 
Despite this initially high observed virulence, follow up studies showed a 
decrease in House finch M. gallisepticum (HFMG) prevalence in a relatively short 
space of time. For example in Auburn Alabama some 60% of the House finch 
population was symptomatic for M. gallisepticum infection in late summer 1996, 
but this had decreased to 9% just two years later in the same season of 1998 
(Roberts et al, 2001). This shift from an epidemic disease ecology to one 
resembling more endemicity within the eastern House finch population suggests 
immediately some degree of host and pathogen adaptation to one another with, 
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in theory, selection processes acting on both host-resistance and pathogen 
virulence. 
Following the host-shift event, phenotypic selection on physical attributes 
in the species was evident very quickly from studies of pre- and post-epidemic 
eastern population birds, with birds surviving infections found to be smaller and, 
in the case of males more brightly coloured than average (Nolan et al, 1998). 
Interestingly however, a recent large-scale analysis of single-nucleotide-
polymorphisms in eastern populations pre and post- epidemic indicated no 
significant genetic signature within the house finch genome attributable the 
outbreak (Shultz et al, 2016). This finding was in stark contrast to other work 
which suggests strong diversifying selection on immune-function associated 
major histocompatibility complex (MHC) loci pre- and post- epidemic (Hawley et 
al, 2012), and the clear emergence of resistance in response to endemic M. 
gallisepticum within a relatively short space of time, evident in the differential 
immune expression and responses of susceptible western and resistant eastern 
population birds to infection post-2007 (Bonneaud et al, 2011, 2012).  
 Additionally, recent findings strongly support the hypothesis that tolerance 
has evolved in H. mexicanus in response to the epizootic alongside resistance, 
with birds from historically exposed populations exhibiting lesser disease 
symptoms at a given bacterial load than those from unexposed populations, but 
also clearing M. gallisepticum infection at a higher rate due to evolved resistance 
(Bonneaud et al, 2018; Bonneaud et al, 2019). As previously discussed, the role 
of tolerance in pathogen evolution is only starting to be well studied, but it seems 
likely that continued research in this area will reveal a more complete picture of 
how real-world coevolutionary processes are likely to occur.    
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Regarding adaptation of M. gallisepticum itself to its novel host in the 
House finch, previous work has shown that despite the decreasing prevalence of 
M. gallisepticum in house finch populations, the bacteria itself has evolved to 
have higher virulence on average over time (Hawley et al, 2010; Hawley et al, 
2013, Bonneaud et al, 2018), with rapid genomic changes to a number of 
virulence and regulatory genes, notably including substantial mutations to 
virulence-associated lipoproteins and. Intriguingly, these studies have also 
shown that substantial losses of CRISPR (clustered regularly interspaced short 
palindromic repeat) sequences and associated cas genes has occurred in M. 
gallisepticum over the epizootic (Tulman et al, 2012; Delaney et al, 2012). 
involved primarily in phage-defence but with potential further ramifications to 
regulatory pathways (Sorek et al, 2008;  Bozic et al, 2019).  
These studies of the co-evolutionary processes between M. gallisepticum 
and H. mexicanus have provided some preliminary evidence to support broadly 
the virulence-transmission trade-off hypothesis. Some previous work has shown 
that a trade-off does appear to present itself between the virulence, host-recovery 
and transmission rates of the pathogen in this novel host, with both higher 
virulence and rates of immune-clearance predictive of faster-transmission 
between hosts (Williams et al, 2014), although firm conclusions from this study 
are hard to make due to the limited library of M. gallisepticum isolates inoculated 
into birds during the experiment. For evolutionary studies such as this, limiting 
the number of isolates used can often fail to capture the variation within time 
points and over large enough time-scales to make strong conclusions as to the 
evolutionary trajectory of pathogens. It is generally considered that early isolates 
of pathogens taken after a host-shift can exhibit great variability in their virulence 
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due to maladaptation to their novel host (Ebert, 1999), and this can be a major 
bias when using small isolate libraries.     
Despite these typical issues of sample size – particularly regarding the 
number of M. gallisepticum isolates used in a normal experiment, such studies 
are helping to build a large set of data of value in answering some of these key 
questions in regards to the evolution of pathogen traits and the evolutionary 
trajectories of emerging infectious diseases, and highlight the applicability of the 
M. gallisepticum – H. mexicanus model system within these fields. Due to the 
spatial separation of western and eastern House finch populations, and with 
minimal contact and gene flow between these populations it has been possible 
to study the responses to infection with various Mycoplasma isolates in both 
“resistant” and “non-resistant” birds from either population, and the large library 
of M. gallisepticum isolates collected from wild House finches over the last 25 
years has insights into both host and pathogen adaptation over time. Using such 
time-shift experiments it has recently been shown that co-evolution between M. 
gallisepticum and H. mexicanus has clearly occurred over time in an antagonistic 
process; M. gallisepticum fitness being tied to whether it is inoculated into a 
“contemporary”, “past” or “future” type host and indicating that virulence has 
evolved adaptively in response to host-resistance (Bonneaud et al, 2018).  
However, despite this relevance and applicability of the system to testing such 
hypotheses, clearly some contention remains over the extent of adaptation of M. 
gallisepticum to its novel host, and conversely in regard to the evolution of 
resistance in the House finch and its impacts on the overall co-evolution occurring 
in the host-pathogen interaction. Over the course of this body of work, we will aim 
to address many of these issues and intend to showcase the M. gallisepticum – 
40 
 
H. mexicanus model system as one of great potential for answering such key 
questions in host-pathogen evolutionary biology. 
Overview of Chapters 
Chapter 2 will address two of the underlying assumptions of the trade-off 
hypothesis; that i) Pathogen virulence will increase with host-resistance over time 
in a novel host-pathogen interaction following a host-shift and ii) Virulence is 
underpinned by pathogen-replication – i.e. that the damage a pathogen causes 
to it’s host is proportional to the rate at which is can replicate and ergo the 
pathogen load in an infection. We utilise a large collection of samples taken 
during an in vivo experimental infection study, with concurrent observational and 
quantitative data on pathogen virulence to trace both how virulence as a trait 
overall has evolved over the epidemic and how replication rates, by contrast have 
changed over the same time-period. 
Chapter 3 considers the role of biofilm formation in M. gallisepticum infections 
and its relation to virulence, as well as its own evolution as a trait. This study 
represents, to this authors knowledge, the first on such a scale considering the 
evolution of biofilm formation in a novel pathogen-host system directly, and of its 
discussion within the larger framework of the trade-off hypothesis.  
 
Chapter 4 reports on the results of a transmission study conducted using the M. 
gallisepticum – H. mexicanus system. Here we measure the rate of transmission 
between experimentally infected birds and secondary sentinel hosts in shared 
enclosures in order to reveal whether transmission rate has changed over the 
course of the epidemic and if, as expected under the virulence-transmission 
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trade-off hypothesis, higher virulence isolates of M. gallisepticum will transmit 
faster than those manifesting lower virulence in vivo. 
 
Chapter 5 concludes the body of this thesis, with a brief exploration of the effects 
of host-resistance on transmission and virulence in a secondary host. The large-
scale population structure of H. mexicanus, containing populations which have 
had long-term exposure (and evolved resistance) to M. gallisepticum, and others 
which have never had circulating M. gallisepticum, allow us to test whether 
passage through either resistant or non-resistant primary hosts immediately 
affects infectivity and virulence in secondary hosts following transmission. 
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Chapter 2: Host resistance increases virulence but not replication rates in 
an emerging pathogen 
 
Abstract 
There is growing evidence that antibiotic treatment selects for pathogens that are 
more harmful to hosts and hence more virulent. Yet how virulence evolves in 
response to host resistance in natural populations, and by which mechanism, 
remains unclear. The virulence-transmission trade-off hypothesis posits that any 
decrease in within-host persistence, for example through host immune clearance, 
should favour faster-transmitting pathogens, with increased virulence assumed 
to arise from the increased replication rates required for faster transmission. Here 
we use the natural outbreak of the bacterial pathogen, Mycoplasma 
gallisepticum, in house finches (Haemorhous mexicanus) from the United States, 
in a rare test of the consequences of host resistance evolution for the evolution 
of both pathogen virulence and replication rates, as well as the role of replication 
rates in shaping virulence. We inoculated non-resistant finches from disease-
unexposed populations with 55 isolates collected over the 20 years of the 
epidemic. We show that replication rates increased from outbreak through to the 
spread of resistance but reached a plateau after hosts had become resistant. In 
contrast, virulence (measured as body mass loss and symptom severity) 
increased linearly throughout the epidemic. In addition, we found a significant 
association between replication rates and symptom severity only when 
considering isolates sampled before the spread of resistance. Taken together, 
our results suggest that replication rates do not underpin virulence and that 
virulence and replication rates may be under independent selection as a result of 
host resistance. Further, they suggest that replication rates may be a strong 
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predictor of pathogen virulence at the start of an epidemic, while traits such as 
immune manipulation subsequently shaping virulence once hosts have become 
resistant. 
 
Introduction 
Understanding the evolution of pathogen virulence in response to host resistance 
is central not only to managing pathogenesis, but also to predicting the long-term 
efficiency of our therapeutic approaches (Boots, 2015, Read et al., 2015, Restif, 
2009). There is growing evidence that host resistance, either through host 
immunity (natural or vaccine-prompted) or antibiotic treatment, selects for 
pathogens that are more virulent (i.e. cause more harm to hosts) (Barclay et al., 
2012, Gandon et al., 2001, Mackinnon and Read, 2004a). Yet the underlying 
mechanisms of virulence evolution remain to be clarified. The classic prediction 
is that host resistance will select for increased replication rates that will enable 
the pathogen to transmit more quickly and escape before it is cleared (Porco et 
al., 2005). Increased virulence then arises because intensified pathogen growth 
accelerates host mortality (de Roode et al., 2008, Doumayrou et al., 2013, Fraser 
et al., 2007). Despite theoretical predictions of an association between virulence 
and replication rates (Alizon et al., 2009, Alizon and Michalakis, 2015), empirical 
evidence is surprisingly limited (Ebert, 1994, Mackinnon and Read, 2004c, Dwyer 
et al., 1990). Resolving the role of variation in replication rates in shaping variation 
in virulence will, however, require experimental contrasts to be made across a 
large number of isolates of a given pathogen that differ in virulence. 
Assumptions of virulence differences shaped by variation in pathogen growth 
are based largely on experimental infections of mice with the rodent malaria 
model Plasmodium chabaudi. Such studies have shown a significant positive 
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association between parasite multiplication rates and measures of both morbidity 
(anemia and weight loss) and mortality (Ferguson et al., 2003, Mackinnon and 
Read, 1999a, Mackinnon and Read, 1999b, Mackinnon and Read, 2004c, Timms 
et al., 2001). Consistent findings emerge from correlational studies of P. 
falciparum, P. vivax and P. malariae and P. ovale in humans, with asexual 
parasitemia found to be positively associated with virulence (McKenzie et al., 
2001, McKenzie et al., 2002, Simpson et al., 2002, Collins and Jeffery, 2002); 
reviewed in (Mackinnon and Read, 2004b). In contrast, correlations made across 
studies failed to detect an effect of pathogen load in explaining virulence 
difference among a range of diseases in both humans and plants (Froissart et al., 
2010, Leggett et al., 2017). Yet, whether this is due to the fact that virulence 
differences are driven by other processes than replication rates, or to the difficulty 
of comparing symptoms and measures of pathogen load across studies of 
different pathogens, remains to be determined. 
The epidemic of the bacterium, Mycoplasma gallisepticum, in house finches 
(Haemorhous mexicanus) from the eastern US offers a rare opportunity to test 
the role of replication rates in shaping changes in virulence among isolates of a 
same pathogen, in response to the spread of host resistance. M. gallisepticum 
first emerged in house finches after a single host shift from poultry, giving rise to 
a severe conjunctivitis outbreak that killed millions and selected for genetic 
resistance in hosts in only 12 years (Bonneaud et at, 2011; Bonneaud et al, 
2012). Indeed, while finches from exposed and unexposed populations initially 
displayed equivalent responses to experimental inoculation, these responses 
subsequently diverged as the former evolved the ability to resist pathogen-
induced immune-suppression and mount a protective cell-mediated immune 
response (Bonneaud et al, 2012). Using a time-shift experimental design, we 
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recently showed that virulence evolved adaptively in response, with the severity 
of eye swelling in symptomatic host increasing significantly as isolates were 
sampled later in the epidemic. 
Here we experimentally contrast virulence and growth patterns among 55 M. 
gallisepticum isolates collected throughout the epidemic and known to differ in 
their level of virulence. To control for confounding effects of host resistance on 
measures of virulence, we inoculated isolates to house finches from populations 
that have never been exposed to the pathogen and hence are unable to mount a 
protective immune response. We previously showed that isolates collected after 
the spread of resistance were three times more likely to cause host mortality than 
isolates collected before the spread of resistance (Bonneaud et al, 2018). We 
now further quantify differences in virulence as the amount of eye swelling and 
mass loss throughout the infection. To quantify bacterial load, we develop a new 
qPCR methodology that allows us to precisely estimate the number of cell copies 
of both the host and the pathogen that we obtained in ocular/tracheal swabs. We 
then test whether changes in virulence over the course of the epidemic were 
accompanied by parallel changes in pathogen growth, and whether any potential 
association between virulence and replication differs before and after the spread 
of host resistance. 
 
Results 
 
Virulence 
We found that the severity eye swelling differed as a function of the year of 
pathogen sampling, with later isolates causing significantly greater eye swelling 
than earlier isolates (linear mixed model; year effect: estimate  se = 1.4  0.4, 
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χ2 = 21.3, p <0.002; Figure 1). Birds lost more body mass when inoculated with 
isolates sampled later in the epidemic (linear mixed model; year effect: estimate 
 se = -0.05 0.02, χ2 = 10.4, df = 1, p = 0.001; Figure 2), independently of their 
body mass at inoculation (year  initial mass interaction effect: χ2 = 2.1, df = 1, p 
= 0.15).  
 
Figure 1. Change in eye swelling severity over time. Quantitative measure of eye 
swelling as a function of the year of pathogen sampling. Points represent raw 
values; the line is predicted from the model with the standard error represented 
by the ribbon. 
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Figure 2. Change in  mass loss due to infection over time. Body mass change as 
a function of the year of pathogen sampling. Points represent raw values, line is 
predicted from the model with standard error represented by ribbon. 
 
Bacterial load 
Overall, there was a significant quadratic relationship between peak bacterial 
load at the site of infection and year of pathogen sampling (linear mixed model; 
year effect: estimate  se = 0.1  0.03, χ2 = 25.4, df = 1, p < 0.0001; year2 effect: 
estimate  se = 7.7  1.3, χ2 = 5.8, df = 1, p = 0.016). Indeed, bacterial load 
increased with year of pathogen sampling for isolates collected between 1994 
and 2007 (pre-resistance), but then plateaued for isolates obtained after 2007 
(i.e. post-resistance) (Figure 3). As a result, while bacterial load differed 
significantly over time among isolates sampled before the spread of host 
resistance (linear mixed model; year effect: estimate  se = 0.2  0.07, χ2 = 6.9, 
df = 1, p = 0.009), isolates sampled after the spread of host resistance achieved 
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similar bacterial loads over the course of the infection (linear mixed model; year 
effect: estimate  se = -0.007  0.05, χ2 = 0.02, df = 1, p = 0.89).  
 
 
 
 
Figure 3. Change in replication rates of M. gallisepticum isolates sampled over 
time. Replication rates increase with time but exhibit a curvilinear trend, 
plateauing later in the epizootic. 
 
Association between virulence and bacterial load 
There was a significant effect of year of pathogen sampling on the association 
between bacterial load and eye swelling (linear mixed model; year  bacterial 
load interaction effect: χ2 = 12.7, df = 6, p = 0.049). The association between 
bacterial load and eye swelling differed significantly between isolates sampled 
before vs. after the spread of host resistance (linear mixed model; sampling 
period  bacterial load interaction effect: χ2 = 32.5, df = 1, p < 0.0001; Figure 4). 
Indeed, while there was a positive association between bacterial load and eye 
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swelling among isolates sampled before the spread of resistance (linear model; 
bacterial load effect: estimate  se = 8.2  2.6, t1,18= 3.1, p < 0.006), this 
association was lost when considering isolates sampled after the spread of 
resistance only (linear model; bacterial load effect: estimate  se = -0.8  3.8, 
t1,24= -0.2, p = 0.83). Results were qualitatively similar for mass change over the 
course of the experiment: there was a significant effect of year of pathogen 
sampling on the association between bacterial load and mass change (linear 
mixed model; year  bacterial load interaction effect: χ2 = 32.8, df = 6, p < 0.0001). 
While there was a negative association between bacterial load and mass change 
in isolates sampled before the spread of host resistance, this association 
disappeared when considering isolates sampled post-resistance (linear mixed 
model; sampling period  bacterial load interaction effect: χ2 = 31.0, df = 1, p < 
0.0001).  
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Fig. 4. The association between bacterial replication and virulence. For pre-
resistance isolates, virulence increases linearly with replication rate, whereas for 
post-resistance isolates no such significant association is evident. 
 
Discussion 
 
Our results show that eye swelling and mass loss increased positively over the 
course of the epidemic, with isolates sampled after the spread of host resistance 
displaying significantly more severe eye swelling and greater mass loss than 
isolates sampled before the spread of resistance. In contrast, pathogen load 
displayed a quadratic relationship with year of isolate sampling, such that 
replication rates increased linearly from outbreak (1994) to the spread of 
resistance (2007), but subsequently plateaued after the spread of host resistance 
(2007-2015). In addition, we found significant associations between our 
measures of virulence, eye swelling and mass change, and pathogen load, but 
only in isolates sampled before the spread of host resistance. Indeed, eye 
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swelling and mass loss increased with increasing pathogen load in pre-resistance 
isolates, but these associations were lost in post-resistance isolates. Taken 
together, our results suggest that increases in pathogen virulence in response to 
host resistance are unlikely to have been mediated by increases in replication 
rates and that, following the spread of resistance, replication rates might have 
been under stabilizing selection. 
It is important to note that our lack of support for an association between 
virulence and replication rates in this system does not, however, bring into 
question the value of the virulence-transmission trade-off for understanding and 
predicting virulence evolution. At the heart of the trade-off hypothesis is the idea 
that increases in pathogen fitness (R0), which represents the number of 
secondary infections arising from a single infected host, can be achieved by 
accelerating between-host transmission or by lengthening the duration of 
infection within the host, but not both (Alizon & Michalakis, 2015, Anderson & 
May, 1982, Ewald, 1983). This is because greater transmission rates require 
greater exploitation of the host and hence greater virulence (Anderson & May, 
1982, Ewald, 1983). While models of virulence evolution have used changes in 
replication rates as the mechanism underlying differences in resistance, a 
positive correlation between virulence and transmission (or a negative one 
between infection duration and transmission) can still arise even if virulence is 
mediated by processes other than changes in pathogen growth.  
M. gallisepticum pathogenesis is primarily dictated by the bacterium’s ability 
to bind host tissues and to evade and manipulate the host immune system 
(Szczepanek et al., 2010a, Szczepanek et al., 2010b, Staley & Bonneaud, 2015, 
Chambaud et al., 1999). Colonization occurs via the mucosal surfaces of the 
conjunctiva and upper respiratory track. This process first requires that M. 
64 
 
gallisepticum erodes/disrupts the mucosal barrier and epithelium by manipulating 
the host immune system into mounting a misdirected inflammatory response 
(d'Hauteville et al., 2002, Hornef et al., 2002, Szczepanek et al., 2010a, 
Szczepanek et al., 2010b, Ganapathy & Bradbury, 2003, Gaunson et al., 2000, 
Gaunson et al., 2006, Lam & DaMassa, 2000), and that the bacterium then 
attaches to host tissues, by instance by binding to proteins of extracellular matrix 
(May et al., 2006). For example, chickens experimentally inoculated with a 
virulent strain of M. gallisepticum (Rlow) displayed a greater up-regulation of pro-
inflammatory cytokines, which are responsible for local and systemic 
inflammation and can give rise to tissue destruction and local necrosis, than 
chickens inoculated with a more attenuated strain (GT5) (Mohammed et al, 
2007). The subsequent persistence of M. gallisepticum then depends on the 
bacterium’s ability to evade and suppress other component of immunity known to 
play a role in controlling M. gallisepticum infection (Gaunson et al, 2006). 
Chickens infected with M. gallisepticum displayed lower T-cell activity 2 weeks 
post-inoculation than controls (Ganapathy and Bradbury, 2003, Gaunson et al., 
2000), as well as lower humoral responses against other pathogens (Matsuo et 
al., 1978, Naylor et al., 1992). This is consistent with the finding that, following 
experimental inoculation, house finches from exposed populations that had 
evolved resistance were able to up-regulate the expression of genes associated 
with acquired immunity (cell-mediated immunity), whereas finches from 
unexposed/susceptible populations instead displayed evidence of a suppression 
of protective immune processes (Bonneaud et al., 2011, Bonneaud et al., 2012). 
Our results of increase virulence, but not of increased pathogen growth, therefore 
suggest that host resistance selected for immune escape/manipulation 
processes rather than increased replication rates. 
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The lack of association between measures of virulence (eye swelling and 
mass loss) and pathogen load in post-resistance isolates suggest that, following 
the spread of host resistance, pathogen replication rates were in fact under 
selection not to increase. Evolutionary stasis may occur if replication rates were 
already optimized for the post-resistance host environment. Alternatively, stasis 
may result from evolutionary constraints if there was an evolutionary trade-off 
between replication rates and the trait underlying increased virulence after the 
spread of host resistance (for e.g. immune avoidance/manipulation 
mechanisms). Further work will be required to better understand the links 
between different pathogen traits and how they evolve in a changing host 
environment. 
Finally, our results support some of the conclusions drawn from the study 
of the myxomatosis outbreak that was triggered in an attempt to eradicate 
European rabbits from Australia in the 1950s. Soon after the release of highly 
virulent isolates of the virus, over 95% of the rabbit population are thought to have 
died. The eradication attempt was, however, unsuccessful because rabbits 
evolved genetic resistance from standing variation within a few years only. 
Although viral virulence initially dropped, the spread of host resistance was found 
to be followed by a rise in the frequency of more virulent viral isolates, leading to 
the same pattern of increased virulence in response to host resistance that we 
find in this study. It is important to note that while the myxoma and the M. 
gallisepticum outbreaks differ in the direction of virulence evolution right at 
disease outbreak (i.e. with virulence decreasing initially in the former but 
increasing in the latter), both patterns of virulence evolution remain consistent 
with theoretical predictions. Indeed, in the case of the myxoma outbreak, 
extremely virulent viral isolates were repeatedly introduced in the rabbit 
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population until they finally succeeded in sparking off an epidemic. However, 
given the disproportionality high level of virulence of the virus and the very high 
susceptibility of the rabbit population, there would have been strong selection 
initially for reduced virulence, at least until resistance spread in the rabbits. A 
similar scenario would have occurred when M. gallisepticum reached western US 
house finch populations after having circulated within eastern US finch 
populations for at least 6 years. The rapid increase in virulence found in our study 
suggest that the isolates that would have reached the unexposed/susceptible 
western populations would have been more virulent than those found at outbreak 
in eastern populations, such that there would have been strong selection for an 
initial decrease in virulence. While the specificities of different 
systems/populations mean that virulence evolution will not necessarily follow the 
same evolutionary trajectory right at outbreak, the concordance of patterns of 
virulence evolution in response to host resistance found in both the myxoma and 
the M. gallisepticum systems suggest that virulence evolution is predictable when 
pathogens are faced with increasingly resistant hosts and that virulence will 
increase over time in such circumstances.   
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Methods 
 
Capture and housing 
Wild house finches from populations that have never been exposed to M. 
gallisepticum were captured in Arizona in the summer 2015. Birds (N = 118, 64 
males and 54 females) that had hatched in the spring 2015 were trapped, 
weighed and banded with a numbered metal tag for individual identification. They 
were then immediately transported by car to aviaries at Arizona State University, 
where they were housed for the remainder of the experiment. On arrival, we 
obtained a blood sample from all birds using brachial venipuncture (60 μL of 
whole blood) and a choanal swab. A lack of prior infection with M. gallisepticum 
since hatching was confirmed by screening blood plasma for anti-M. 
gallisepticum antibodies using a serum plate agglutination assay (Luttrell et al., 
1996), and a lack of current infection was verified using the choanal swabs in 
PCR amplification of M. gallisepticum DNA (Roberts et al., 2001). This was 
expected as M. gallisepticum has never been documented in the area of Arizona 
in which sampling was conducted (Staley et al., 2018). We used 53 individuals in 
another experiment, and all remaining 118 birds were housed in cages as 54 
randomly-assigned female-male pairs and 5 male-male pairs. The birds were 
then allowed to acclimate for one month prior to experimental onset and provided 
with ad libitum food and water throughout. None of the birds displayed any sign 
of infection with other diseases and all birds were similarly treated for infection by 
Trichomonas gallinae and Coccidia spp in the first few weeks of captivity.  
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Experimental inoculation 
One bird randomly selected from each of the 59 pairs was inoculated with 1 of 56 
M. galliseptum isolates sampled over the course of the epidemic. Isolates were 
administered via 20 μL of culture containing 1 × 104 to 1 × 106 color changing 
units/mL of M. galliseptum in both eyes. None of the isolates had been passaged 
in culture more than 3 times (Papazisi et al., 2002). The second bird of each pair 
remained uninfected and used in another study. We monitored the development 
of clinical symptoms in the experimentally-inoculated bird by visually scoring eye 
lesion severity at both eyes (0–5 scale; (Kollias et al., 2004)) at 3, 6, 8, 14, 21, 
25, 28 and 34 days post-infection (dpi). For those birds that developed symptoms, 
we photographed the right and left eyes at 0, 6, 13 and 25 days post-inoculation 
(dpi). We then quantified the area of the conjunctiva swelling at each day as the 
area of the outer ring minus the area of the inner ring (see Staley et al 2017). 
Measurements of photographs were done blindly with respect to the isolate 
inoculated. Mean eye swelling severity was then determined as the mean value 
reached by the experimentally inoculated bird over the course of the experiment. 
All birds were weighed (±0.01 g) at the start and at the end of the experiment 
using a top-pan balance. The experiment was stopped at 35 dpi and all birds 
were euthanized as stipulated by home office licencing. Protocols were approved 
by Institutional Animal Care and Use Committees (IACUC) of Auburn University 
(permit # PRN 2015-2721) and Arizona State University (permit #15-1438R), and 
by Institutional Biological Use Authorizations to Auburn University (# BUA 500). 
 
Bacterial load 
No significant effect of any variation in inoculum dose was found on pathogen 
load or conjunctival swelling at any time-point subsequently sampled in this 
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experiment (Fig. 6 and Fig.7.). Furthermore, we investigated the appropriateness 
of our measure of pathogen replication rate by comparing it to pathogen load 
determined at each sampling time point (Fig.8).   
We re-designed and optimised a qPCR assay for the single-copy M. gallisepticum 
mgc2 and H. mexicanus rag1 genes(Grodio et al., 2008), with the aim of 
improving amplification specificity and efficiency. Notably, our assay includes: (1) 
shorter amplicons for faster amplification; (2) primers and probes designed for 
near identical thermodynamics between mgc2 and rag1 in order to promote high 
efficiencies in multiplex reactions; (3) lower background signal due to refined 
fluorophores and quenching. We designed oligonucleotide probes and primers 
from consensus assemblies of M. gallisepticum mgc2 gene sequences (Genbank 
IDs: CP003513.1, CP003512.1, CP003511.1, CP003508.1, CP003507.1, 
CP003509.1, CP003506.1, CP003510.1) and of H. mexicanus (and other closely 
related Haemorhous/Carpodacus species) rag1 gene sequences (Genbank IDs: 
EU165349.1, EU165350.1, KJ455991.1, KJ455990.1, KJ455989.1, KJ455986.1, 
KJ455985.1, KJ455992.1, KJ455988.1), using Geneious™R8 v.8.1.8 (Kearse et 
al., 2012) and Primer3 (Untergasser et al., 2012), and checked for specificity with 
Primer BLAST (Ye et al., 2012) (see Table 1 for sequences and details of oligos). 
Standard curves for both mgc2 and rag1 amplicons were produced by cloning of 
approx. 600bp gene fragments from M. gallisepticum strain RLow and from an 
uninfected Arizona population control bird respectively into separate pCR™2.1 
plasmid vectors in Escherichia coli, using an Invitrogen™ TA Cloning™ Kit 
according to manufacturer standard protocols. Plasmids containing target 
sequences were validated by restriction endonuclease analysis and checked for 
specific binding of internal primers by PCR and gel electrophoresis. 10-fold 
dilution series of plasmids containing either mgc2 or rag1 target sequences were 
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quantified using a Qubit™ dsDNA HS Assay Kit, and their accuracies and 
efficiencies further verified by qPCR as individual and multiplexed reactions. The 
final range of standards used in experiments was approx. 1.6x108 – 1.6x103 mgc2 
target copies and 8.0x107 – 8.0x102 rag1 target copies (Fig. 5). Limits of detection 
and quantification were determined by extinction dilution of standards (Forootan 
et al., 2017), with limits of quantification set to a threshold coefficient of variation 
(CV) of 35%, representing absolute values of 28 target copies for mgc2 and 18 
target copies for rag1. 
 Further validation of plasmid standards was made by comparison of 
amplification efficiencies between plasmid DNA and genomic DNA template 
serial dilutions, as well as with genomic DNA spiked with known quantities of 
plasmid DNA. First, we calculated the cycle-based efficiency of plasmid and 
genomic DNA template serial dilutions. StepOne™ Software v2.3 (ABI) reported 
typical efficiency values of 92.7% and 91.7% respectively for rag1 amplification 
from plasmid DNA and genomic DNA templates and 96.4% and 94.3% 
respectively for mgc2 amplification from plasmid DNA and genomic DNA 
templates. Additionally, LinRegPCR calculated mean efficiencies (across 
multiple runs and replicates) for mgc2 from genomic DNA at 83.3% (n=1137), for 
mgc2 from plasmid DNA at 83.2% (n=128), for rag1 genomic DNA at 85.3% 
(n=1137) and for rag1 from plasmid at 85.2% (n=128). N.B. LinRegPCR typically 
produces lower efficiency values than other methods due to differences in 
efficiency calculations and the greater variation in efficiencies observed when 
measuring reactions independently. Second, we conducted genomic DNA and 
plasmid spike tests. Amplification efficiencies of mgc2 and rag1 from either 
plasmid or genomic DNA was further verified by spiking dilutions of genomic DNA 
with known quantities of plasmid DNA targets. 10-fold dilutions of house finch or 
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M. gallisepticum genomic DNA were measured independently and when spiked 
with known quantities of pCR2.1-rag1 or -mgc2 plasmid (827 rag1 and 1709 
mgc2 copies respectively). Accuracy was determined by linear regression of 
observed copy number against expected copy number (genomic DNA + plasmid) 
in each reaction. rag1 amplification from genomic DNA spiked with plasmid DNA 
observed vs. expected copy number coefficient = 1.03  0.04, mgc2 amplification 
from genomic DNA spiked with plasmid DNA observed vs. expected copy number 
coefficient = 1.00  0.006, indicating that amplification efficiencies are analogous 
between plasmid or genomic DNA templates.  
 Bacterial load was measured from conjunctival and tracheal swabs obtained 
at 8, 14, 21 and 28 dpi by quantifying the number of M. gallisepticum mgc2 gene 
copies and the number of house finch rag1 gene copies using a re-designed 
qPCR assay (Grodio et al., 2008) (Table 2 and Supplementary Methods for assay 
design and validation). The gene mgc2 encodes a cytadhesin protein and is 
present at one copy/M. gallisepticum genome, while the recombination-activating 
gene rag1 is present in two copies/diploid house finch cell (Grodio et al., 2008). 
Pathogen load is then determined as the number of M. gallisepticum cells divided 
by the number of house finch cells to control for variation in sampling efficiency 
(Grodio et al., 2008). DNA was extracted using a QIAGEN DNeasy® Blood and 
Tissue Kit according to the manufacturer’s standard protocols. Multiplex qPCRs 
for mgc2 and rag1 were then conducted using an Applied Biosystems™ 
StepOnePlus™ Real-Time PCR system. Sample concentrations were 
determined by comparison to standard curves of both mgc2 and rag1 amplicons. 
These amplicons were produced by cloning of approx. 600bp gene fragments 
into separate pCR™2.1 plasmid vectors in Escherichia coli, using an Invitrogen™ 
TA Cloning™ Kit according to manufacturer standard protocols. The final range 
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of standards used was approx. 1.6x108 – 1.6x103 mgc2 target copies and 8.0x107 
– 8.0x102 rag1 target copies. Each multiplex qPCR reaction was run in a final 
volume of 20 µl and contained: 2µl of either plasmid standard or sample genomic 
DNA template, 1 µl each of 10 µM mgc110-F/R and rag1-102-F/R primers (total 
4ul; Table 2), 0.5 µl each of 10 µM Mgc110-JOE and Rag1-102-FAM fluorescent 
hydrolysis probes (total 1 µl), 10 µl of 2X qPCRBIO Probe Mix HI-ROX (PCR 
BIOSYSTEMS) and 3 µl Nuclease-free water (Ambion®). Cycling conditions 
were as follows: 95°C for 3 minutes for initial denaturing of template DNA, 
followed by 45 cycles of 95°C for 1 second and 60°C for 20 seconds for primer 
and probe binding and amplification of target DNA. Samples and standards were 
measured in duplicate in each run with a negative control of elution buffer. All 
data was exported to LinRegPCR v.2017.1 for calculation of individual reaction 
efficiencies and quantification of low-amplification samples (Ruijter et al., 2009, 
Tuomi et al., 2010). Between-run variation was normalised using Factor qPCR 
v.2016.0 (Ruijter et al., 2015), with standard series presented as between-run 
replicates. 
 
Statistical analyses 
All statistical analyses were conducted in R 3.3.2 (Team, 2016) using lme4 (Bates 
et al., 2015), and figures were made using ggplot2 (Wickham, 2009). Pathogen 
load data were log-transformed to fit a normal distribution. To determine how 
virulence and replication rates evolved over the course of the epidemic, we ran 
linear mixed effects models, with year of pathogen sampling (year) as the 
explanatory term and pathogen isolate as the random effect. We included either 
mean eye swelling, body mass at the end of the experiment (i.e. 34 dpi), or peak 
pathogen load as the response term. For changes in body mass, we included 
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initial body mass at inoculation in interaction with year as explanatory terms. To 
determine how virulence and replication rates differ between isolates sampled 
before and after the spread of host resistance, we ran the same 3 models but this 
time including the sampling period of the pathogen (i.e. pre- or post-resistance) 
as the explanatory term. We tested for differences in virulence over the course of 
the infection using linear mixed effect models that included either eye swelling or 
body mass were as the response variable, the day of the infection (dpi) and either 
the year of pathogen sampling (year) or the pathogen sampling period (pre- vs. 
post-resistance) and their interactions as the explanatory terms, and with 
pathogen isolate as the random term. Body mass at inoculation was included in 
the model of body mass change. Tests of the association between virulence and 
pathogen load were run as linear mixed effect models with pathogen load and 
either the year of pathogen sampling (year) or the pathogen sampling period (pre- 
vs. post-resistance) and their interaction as the explanatory terms, and with 
pathogen isolate as the random term. We included either mean eye swelling or 
body mass change between inoculation and 34 dpi as the response variable. 
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Table 1: Primers and probes used in the quantification of bacterial load. 
6FAM/JOE- fluorophore moieties for probes. BHQ1 – Black-hole quencher 1. [+N] 
– modified LNA base. 
Name Sequence Target Use 
Rag1-608-F 5’-TCATCCTGCTGTCTGTCTGG-3’ 608bp fragment of 
rag1 from 
H.mexicanus 
genomic DNA 
Construction of 
pCR™2.1 – rag1 
plasmid for standard 
curves 
 
Rag1-608-R 
 
5’-GATCCGATTCATCAGCCAGC-3’ 
Rag1-102-F 
 
5’-GCCCTCCTACCAGGTTATCA-3’ Internal sequence of 
pCR™2.1-rag1 
plasmid 
Amplification of rag1 
target for probe 
binding in qPCR Rag1-102-R 
 
5’-TGGCAGTCCTGATAGTCCAT-3’ 
 
Rag1-102-
FAM 
5’-[6FAM]-
TTGAGTGGAAACCTC[+C][+C][+C]TGA-
[BHQ1]-3’ 
Internal sequence of 
Rag1-102 amplicon 
 
Quantification of 
Rag1-102 amplicon 
in multiplex qPCR 
Mgc2-597-F 5’-GGTGCTGGGTTGATTGTTGT-3’ 597bp fragment of 
mgc2 from genomic 
M. gallisepticum 
DNA 
Construction of 
pCR™2.1 – mgc2 
plasmid for standard 
curves 
Mgc2-597-R 5’-GTGATTAAACCCACCTCCAGC-3’ 
Mgc110-F 5’-AATGCCACCAAGACCAAACT-3’ Internal sequence of 
pCR™2.1-mgc2 
plasmid 
Amplification of mgc2 
target for probe 
binding in qPCR 
Mgc110-R 5’-CAGCTTTATTTCCCATCGGC-3’ 
Mgc110-JOE 5’-[JOE]-[+A]ACCAAGACCAGGTTTC[+A]GAC-
[BHQ1]-3’ 
Internal sequence of 
Mgc2-110 amplicon 
Quantification of 
Mgc2-110 amplicon 
in multiplex qPCR 
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Figure 5. Linearity of (A) mgc2 and (B) rag1 standard curves from linear 
regression of standard dilution series (n=32) copy number against factor-
corrected starting concentrations calculated using LinRegPCR. 
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Fig. 6. The effect of inoculum dose size on measures of bacterial load. Top row 
– 8 dpi, 14, dpi. Bottom row – 21 dpi, 28 dpi. Dose size effect was non-significant 
at every time point. Linear regressions of log10 Bacterial Load ~ Inoculum size, -
1.78e-10 +/- 8.95e-09 (8 dpi), -1.10e-08 +/- 1.07e-08 (14 dpi), -9.20e-11 +/- 
8.16e-09 (21 dpi), 6.34e-09 +/- 1.06e-08 (28 dpi).  
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Fig. 7. The effect of inoculum dose size on measures of virulence (as conjunctival 
swelling). Top row – 6 dpi, 13, dpi. Bottom row – 25 dpi, 34 dpi. Dose size effect 
was non-significant at every time point. Linear regressions of log10 conjunctival 
swelling (pixels) ~ Inoculum size, coef = -5.24e-10 +/- 2.25e-09 (6 dpi), -2.37e-
09 +/- 2.59e-09 (13 dpi), 5.02e-10 +/- 4.34e-09 (25 dpi), 3.82e-10 +/- 4.04e-09 
(34 dpi).  
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Fig. 8. The association of replication rate to bacterial load measured at 8, 14, 21 
and 28 dpi. Replication rate is highly predictive of bacterial load at all time points. 
coef = 0.28 +/- 0.028, F1, 54 = 102.8, p = 4.18e-14 (8 dpi), coef =  0.28 +/- 0.043, 
F1, 53 = 40.72, p = 4.45e-8 (14 dpi), coef = 0.18 +/- 0.36, F1, 53 = 25.61, p = 5.36e-6 
(21 dpi), coef = 0.0041 +/- 0.0019, F1, 53 = 4.83, p = 0.0324 (28 dpi). 
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Chapter 3: Evolution of biofilm formation ability in an emerging bacterial 
pathogen 
 
Abstract 
 
Microbial life in natura is often restricted to growth on solid strata in the form of 
biofilms. In this sessile form of living, microbial species and communities can be 
found in structurally and demographically complex structures and the structural, 
metabolic and genetic heterogenicity present in these biofilms could have major 
implications for microbial evolutionary processes as well as large impacts on host 
responses in the case of pathogenic infecting microbes. Additionally, the role of 
biofilms and its relationship with microbial pathogenesis and virulence in an 
evolutionary context is largely unknown. In this chapter we use the M. 
gallisepticum – H. mexicanus system to study how a bacterial pathogens ability 
to form biofilms has evolved in response to growing host resistance, and whether 
this has played a role in how other traits, i.e. the pathogens virulence, have 
changed over time. Low-passage isolates of M. gallisepticum sampled across the 
epizootic and used concurrently in an in vivo study experimental infection were 
grown in vitro and allowed to form biofilms. These were then stained with crystal 
violet in order to assay the abundance of biofilm produced by each isolate. Using 
this data, we show that the biofilm forming capability of M. gallisepticum isolates 
has decreased on average over time and that these decreases have occurred 
concurrently with the increasing average virulence of the pathogen, suggesting 
that the loss of biofilm forming ability in M. gallisepticum has occurred in response 
to host-resistance and selection to maintain or increase its virulence in its novel 
host. 
88 
 
Introduction 
 
Understanding the mechanisms by which pathogens mitigate host immune 
defences is critical to predicting pathogenesis and virulence evolution. Theory 
predicts that host resistance via immune activity will select for pathogens that can 
transmit rapidly before they are cleared by the immune system (MacKinnon & 
Read, 1999; Mackinnon & Read, 2004). Since faster transmission rate requires 
greater levels of host exploitation and damages, host resistance should select for 
more virulent pathogens. Such increases in virulence can occur, for example, as 
a result of increasing rates of pathogen replication within the host, or as a 
consequence of immune manipulation and escape (Foster, 2005). While there is 
accumulating empirical evidence for the evolution of increasing virulence in 
response to host resistance (Chapter 1), less is known about the mechanisms 
mediating virulence evolution.  
One mechanism by which bacterial pathogens can persist in hostile host 
environments and either escape and/or modulate host immunity, is through 
forming biofilms (Vuong et al, 2004). Biofilms consist of aggregated bacteria that 
are embedded within a complex matrix of extracellular polymeric substances and 
adhered to a solid surface (Dunne, 2002). The extracellular polymeric substances 
at the surface of biofilms can form a physical barrier that protects against host 
immunity (Domenech et al, 2013). For example, Staphylococcus aureus in 
biofilms are shielded from phagocytosis by macrophages, most likely as a result 
of the size and/or physical complexity of the biofilm (Thurlow et al,2011). In 
addition, biofilm formation can disrupt and modify immune processes. For 
example, in Pseudomonas aeruginosa and Candida albicans, biofilm formation 
is associated with strong, but ineffective inflammatory responses (Alhede et al, 
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2014). However, although phagocytes can mount an oxidative burst response 
against P. aeruginosa biofilm, they become immobilised following contact and 
can no longer migrate away (Jesaitis et al, 2003). S. aureus biofilms can also 
cause macrophage dysfunction and apoptosis upon physical contact (Cerca et 
al, 2006), most likely as a result of exposure to toxic by-products of bacterial 
metabolism or lytic toxins (Hanke & Kielian, 2012). C. albicans biofilms, on the 
other hand, do not trigger a reactive oxygen response and instead appear to have 
an immunosuppressive effect, with monocytes becoming entrapped in the biofilm 
ultrastructure (Chandra et al,2007; Katragkou et al, 2010; Xie et al, 2012). That 
biofilms can be used as a means of protection against the immune system is 
evidenced by the fact that immune activity can stimulate biofilm formation. For 
example, the presence of polymorphonuclear neutrophils has been shown to 
increase biofilm formation in P. aeruginosa by a factor of 2-3.5 times (Walker et 
al, 2005; Parks et al, 2009). Although biofilms have been shown to protect 
bacterial pathogens against host immunity, by acting as a physical barrier and/or 
by modifying the immune response, the role of biofilm formation in driving 
virulence evolution in response to host resistance remains to be determined.   
The emergence of the bacterial pathogen, Mycoplasma gallisepticum, in a wild 
North American songbird, the house finch (Haemorhous mexicanus), offers a rare 
opportunity to test how the role of biofilm formation ability in pathogen virulence 
evolution in response to the spread of host resistance. M. gallisepticum jumped 
from poultry into house finches in 1994, giving rise to a severe conjunctivitis 
outbreak that killed millions (Delaney et al, 2012; Dhondt et al, 1998). Faced with 
the intensity of this selection event (Gates et al, 2018), disease-exposed house 
finch populations evolved genetic resistance in less than 12 years (Bonneaud et 
al, 2012). The evolution of host resistance, in turn, gave rise to an adaptive 
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increase in pathogen virulence (Bonneaud et al, 2018; Chapter 1). While 
virulence increased linearly over the course of the epidemic, replication rates 
increased from outbreak through to the spread of resistance but reached a 
plateau after hosts had become resistant (Chapter 1). This indicates that 
increasing replication rates do not underpin increasing virulence in this system, 
and that virulence and replication rates may be under independent selection as 
a result of host resistance. 
Here, we investigate the biofilm formation ability of 55 distinct M. gallisepticum 
isolates collected from epidemic outbreak, throughout the initial spread of host 
resistance and afterwards to present day (1994-2015). We have shown 
previously that these isolates differ in virulence, as measured by increased 
conjunctival swelling and putative host mortality (Chapter 1 of this thesis). In this 
study, we test whether biofilm formation mediates, at least in part, the evolution 
of increasing pathogen virulence in response to the spread of host resistance. To 
do so, we measured the amount of biofilm produced in vitro by each of the 
isolates for which measures of virulence were taken in vivo during an 
experimental inoculation of non-resistant house finches (see Chapter 1). This 
allowed us to test: (i) how biofilm formation ability has changed over the course 
of a naturally-evolving epidemic; and (ii) the association between pathogen 
virulence and biofilm formation ability in the face of increasing host resistance.  
We predict that, if biofilms formation has been under selection as a means of 
protection against host resistance, then the amount of biofilm produced by 
isolates should increase over the course of the epidemic and should be positively 
associated with measures of virulence. In contrast, if another pathogen trait 
drives the adaptive increase in virulence over time but trade-offs with biofilm 
formation, then biofilm production should decrease over time and should be 
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negatively associated with measures of virulence. Alternatively, if biofilm 
formation plays no role in pathogen evolution in this system, then there should 
be no change in the amount of biofilm produced over time and no association 
with measures of virulence. Finally, given the commonly-assumed role of 
pathogen load in shaping virulence (see Chapter 1), we also test for any 
association between pathogen load and amount of biofilm produced. 
 
Results 
 
45 out of 47 isolates (96%) were found to have produced a detectable level of 
biofilm in vitro. The average amount of biofilm produced, measured by optical 
density was A595 0.023 We found a negative linear association between amount 
of biofilm produced and year of pathogen sampling, with late epidemic isolates 
forming significantly less biofilm than earlier ones (linear model: estimate  se = 
-0.091   0.034, F1,44 = -2.69, p = 0.010; Fig. 1). Furthermore, we found significant 
negative associations between biofilm formation and the two measures of 
virulence. The amount of biofilm produced decreased significantly with increasing 
conjunctival swelling of the host in vivo (linear model: estimate  se = -0.021   
0.006, F1,44 = -3.94, p < 0.0003; Fig. 2). Furthermore, the amount of biofilm 
produced was significantly lower in hosts that would have died in the wild as a 
result of infection (linear model: estimate  se = -1.39   0.47, F1,44 = -2.97, p < 
0.005; Fig. 3). Finally, we found no association between the amount of biofilm 
produced and the total pathogen load achieved over the course of an infection in 
vivo (linear model: estimate  se = -0.00014   0.00018, F1,44 = -0.80, p = 0.43).   
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Figure 1. Changes in biofilm production over the course of the epidemic. We 
show changes in the amount of biofilm produced as pathogen isolates were 
sampled progressively later in the epidemic. Points represent raw values; the line 
is predicted from the model with the standard error represented by the ribbon. 
 
 
Figure 2. Association between biofilm formation and conjunctival swelling. We 
show the amount of biofilm produced (ln transformed) as a function of mean 
conjunctival swelling (in pixels), with greater amounts of biofilm produced being 
associated with lower virulence. Points represent raw values; the line is predicted 
from the model with the standard error represented by the ribbon. 
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Figure 3. Association between biofilm formation and host mortality. Boxplot 
diagram showing amount of biofilm produced (ln transformed OD595) for isolates 
that have versus have not caused putative host mortality. Depicted are the 
median and range transmission rates; points represent raw values. 
 
Discussion 
 
By taking advantage of a large repository of bacterial isolates of known virulence 
in vivo that were collected over the course a natural epidemic since initial 
outbreak and over the next 20 years, we were able to test key questions about 
the role of biofilm formation ability in the evolution of pathogen virulence in 
response to host resistance. We found that the amount of biofilm produced 
decreased significantly over time and was negatively associated with two 
measures of virulence (conjunctival swelling and putative mortality). The amount 
of biofilm produced, however, was not associated with the total bacterial load 
achieved at the site of infection in vivo, indicating no association between biofilm 
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formation ability and pathogen replication rate. Our findings suggest that another 
mechanism has driven the evolution of increasing virulence in response to host 
resistance and that this mechanism trade-offs with biofilm formation ability. What 
this mechanism is and how it trades-off with biofilm formation, however, remains 
to be determined. 
The link between biofilm formation and virulence has primarily been 
investigated through a comparison of chronic versus acute infections. For 
instance, Pseudomonas aeruginosa biofilms appear to be instrumental in the 
establishment of chronic respiratory infections of cystic fibrosis patients (Starkey 
et al, 2009). Furthermore, Neisseria meningitidis biofilm forming isolates are more 
commonly associated with asymptomatic infections in “carrier” individuals and 
less prevalent in the highly virulent invasive infections causing bacterial 
meningitis (Yi et al, 2004). Finally, in porcine hosts, the capability of 
Streptococcus suis isolates to form biofilms appears to bias infections towards a 
chronic persistent state (Wang et al, 2011; Vötsch et al, 2018). Our finding of a 
negative association between amount of biofilm produced and virulence is 
consistent with these findings and suggest that mechanisms that favour more 
aggressive pathogens may also lessen their stealth behaviour. 
Unravelling the relationship between biofilm formation and virulence in M. 
gallisepticum, particularly in the context of emergent resistance and tolerance in 
the House finch (Bonneaud et al, 2018; Bonneaud et al, 2019), will require further 
work aimed at understanding the immunopathological consequences and 
mechanisms underpinning them. In the well characterised Pseudomonas 
aeruginosa system, biofilm production is known to have myriad effects across 
both innate and secondary immunity processes. For example, P. aeruginosa 
biofilms appear to be highly activating of innate immune effectors, largely through 
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the activation of neutrophils, but also difficult for these defences to attack 
efficiently (Moser et al, 2017). This is thought to lead to immunopathology in cystic 
fibrosis patients due in large part to the long-term activation of the oxidative-burst 
neutrophil response and it’s associated “bystander” host-damage (Kolpen et al, 
2014). In Mycoplasma pulmonis at least, a similar phenomenon in the activation 
of the complement system appears to occur. M. pulmonis biofilms appear to 
provide structural protection from the effects of host complement and gramicidin 
innate immune effectors, whilst still being highly-activating of these immune 
responses (Simmons et al, 2007). In contrast, the evolution of resistance to M. 
gallisepticum by H. mexicanus has been shown to have been mediated by cell-
mediated immunity, and the downregulation of innate (inflammatory) immunity 
genes, including those involved in complement cascade activation in unexposed 
finch populations on infection with a 2007 M. gallisepticum isolate (Bonneaud et 
al, 2012). Squaring this data with our results here and within the context of 
immunopathology and resistance/tolerance evolution will require further work. 
However, we consider broadly that perhaps selection to increase or maintain 
virulence (linked to transmission), in response to the lower immunopathology in 
resistant/tolerant birds has led to a shift in the immunomodulatory behaviours of 
M. gallisepticum. If the mechanisms by which resistance/tolerance has evolved 
are focused on a narrow set of immune-responses, there may be the potential for 
M. gallisepticum to in turn evolve anti-resistance/tolerance strategies by shifting 
how it interacts with these host-immune processes.  
      The lack of any significant association between biofilm formation and 
pathogen replication found in this experiment is perhaps not surprising. Previous 
studies attempting to link replication and biofilm formation have indicated a 
complex and hard to predict relationship between the two. In Pseudomonas 
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aeruginosa it has been suggested that so long as the microenvironment around 
cells is the same, the growth kinetics between planktonic and sessile biofilm cells 
should be constant (Bakke et al, 1994). On the other hand, a number of studies 
have shown either decreased or increased growth rates in biofilms relative to 
planktonic cells measured under various conditions (van Loosdrecht et al, 1990). 
Perhaps the takeaway from this research is that these contrasting findings on the 
relationship between biofilms and microbial replication appear as a result of the 
complicated and variable structural and environmental conditions of biofilms, as 
well as differences in the biology of primary (biofilm forming) and secondary 
(growing in existing biofilms) cells (Rice et al, 2000). Developing assays for 
biofilm formation which adequately address the methodological issues in making 
accurate and biologically relevant measurements of biofilm forming capability are 
critical to furthering our understanding of their importance for both environmental 
and pathogenic microbes. 
Although we acknowledge these obvious limitations and others presented by 
the study presented herein, we consider that this work should contribute to our 
understanding of select on biofilm formation. That in vivo biofilm formation may 
be quite different in character to the behaviour of M. gallisepticum in in vitro 
infection conditions is a clear issue, but we would nevertheless suggest that the 
propensity of our isolates to form biofilms under the conditions used should bear 
some relevance to its biology within the host. in vivo studies of biofilm formation 
which could resolve this are notoriously difficult and full of confounding factors, 
making it difficult to control for or design experiments which can produce the 
amount of data needed to draw evolutionary conclusions. We hope that follow up 
work from this study will help to address such issues, for example by identifying 
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biofilm associated genetic and transcriptional biomarkers which might facilitate 
indirect determination of M. gallisepticum biofilm formation in vivo.  
 
Methods 
 
Biofilm formation culture and crystal violet staining  
Low passage inoculum stocks of M. gallisepticum as used in the in vivo 
experimental infection above where inoculated into 10ml of Mycoplasma Broth 
media supplemented with Mycoplasma selective supplement G (OXOID) and 
concentrations standardised to an OD595 of 0.01. 10-fold dilutions of 
standardised cultures were made using fresh media and added in triplicate to 
each of 2 rounded bottom 96-well culture plates. Each plate contained in triplicate 
a negative control of media from the same batch as used for initial cultures and 
a positive control/standardisation factor of RLow, a widely studied and consistently 
high-biofilm producing M. gallisepticum isolate from poultry (Chen et al, 2012). 
Plates were sealed and incubated for 72hrs at 37C and 5% CO2. 
Plates were removed from the incubator and media gently aspirated from 
each well, washed twice with 1x PBS solution and left to dry upside-down on 
paper for 5 minutes. When dry, 200ul of 100% MeOH was added to each well to 
fix and permeabilise biofilms and left to incubate for 10 minutes at room 
temperature. MeOH was then aspirated from wells and plates left to dry face up 
for 10 minutes to remove any trace solvent. When dry, 150ul of 0.5% Crystal 
Violet solution was added to each well and plates were left to incubate at room 
temperature for 45 minutes to ensure thorough staining of biofilms. Plates were 
then washed extensively 6x with sterile d.H20 to remove any unbound CV and 
left to dry for 10 minutes. To dislodge biofilms and dissolve bound CV we added 
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200ul of 30% Acetic Acid to each well and placed plates on a rotating mixer at 
120 rpm for 20 minutes. 100ul of solvent from each well was then transferred into 
corresponding wells on a flat-bottom 96-well plate for spectrophotometry, the 
OD595 of each well were measured and mean values calculated for each M. 
gallisepticum isolate on each plate. Between plate normalisation was performed 
using factor-correction in Factor (Rutjer et al, 2006), with mean RLow values per 
plate used as the standardisation factor. 
 
Experimental inoculation 
Wild house finches from populations that have never been exposed to M. 
gallisepticum were captured in Arizona in the summer 2015. Birds (118, 64 males 
and 54 females) that had hatched in the spring 2015 were brought back to 
aviaries at Arizona State University and housed independently. A lack of prior 
infection with M. gallisepticum since hatching was confirmed by screening blood 
plasma for anti-M. gallisepticum antibodies using a serum plate agglutination 
assay (Luttrell et al. 1996), and a lack of current infection was verified using the 
choanal swabs in PCR amplification of M. gallisepticum DNA (Roberts, Nolan, 
and Hill 2001). Birds were randomly inoculated with 1 of 55 M. gallisepticum 
isolates sampled over the course of the epidemic (see Chapter 1). The 
experiment was stopped at 35 dpi and all birds were euthanized as stipulated by 
home office licencing. Protocols were approved by Institutional Animal Care and 
Use Committees (IACUC) of Auburn University (permit # PRN 2015-2721) and 
Arizona State University (permit #15-1438R), and by Institutional Biological Use 
Authorizations to Auburn University (# BUA 500). 
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Virulence 
To quantify the size of the conjunctiva and so severity of conjunctival swelling, 
we photographed the right and left eyes at 0, 6, 13 and 25 days post-inoculation 
(dpi) from a standardized distance. We then measured the average area of the 
conjunctiva swelling across the two eyes and at each day as: the area of the outer 
ring minus the area of the inner ring at 6, 13 or 25 dpi - the area of the outer ring 
minus the area of the inner ring at 0 dpi (Staley et al, 2018). Measurements of 
photographs were done blindly with respect to the isolate inoculated. Finally, eyes 
were also inspected visually on days 3, 6, 8, 14, 21, 25, 28 and 34 post-infection: 
infection is considered lethal when the conjunctiva is red to purple, and the eye 
is difficult to see and produces discharge – such symptoms, with little or no vision 
possible, are thought to have caused the death of millions of infected finches due 
to starvation or predation (Adelman et al, 2017; Kollias et al, 2004; Roberts et al, 
2001).  
 
Pathogen load  
Bacterial load was measured from conjunctival and tracheal swabs obtained at 
8, 14, 21 and 28 dpi by quantifying the number of M. gallisepticum mgc2 gene 
copies and the number of house finch rag1 gene copies (Tardy et al submitted). 
Pathogen load was then determined as the number of M. gallisepticum cells 
divided by the number of house finch cells to control for variation in sampling 
efficiency (Grodio et al, 2008). DNA was extracted using a QIAGEN DNeasy® 
Blood and Tissue Kit according to the manufacturer’s standard protocols. 
Multiplex qPCRs for mgc2 and rag1 were conducted using an Applied 
Biosystems™ StepOnePlus™ Real-Time PCR system. Each multiplex qPCR 
reaction was run in a final volume of 20 µl and contained: 2µl of either plasmid 
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standard or sample genomic DNA template, 1 µl each of 10 µM mgc110-F/R and 
rag1-102-F/R primers (total 4ul; Table 2), 0.5 µl each of 10 µM Mgc110-JOE and 
Rag1-102-FAM fluorescent hydrolysis probes (total 1 µl), 10 µl of 2X qPCRBIO 
Probe Mix HI-ROX (PCR BIOSYSTEMS) and 3 µl Nuclease-free water 
(Ambion®). Cycling conditions were as follows: 95°C for 3 minutes for initial 
denaturing of template DNA, followed by 45 cycles of 95°C for 1 second and 60°C 
for 20 seconds for primer and probe binding and amplification of target DNA. 
Samples and standards were measured in duplicate in each run with a negative 
control of elution buffer. All data was exported to LinRegPCR v.2017.1 for 
calculation of individual reaction efficiencies and quantification of low-
amplification samples (Ruijter et al, 2009; Tuomi et al, 2010). Between-run 
variation was normalised using Factor qPCR v.2016.0 (Ruijter et al, 2015), with 
standard series presented as between-run replicates.  
 
Statistical analyses 
All statistical analyses were conducted in R 3.3.2 (Team 2016) and figures were 
made using ggplot2 (Wickham, 2009). In all analyses, the amount of biofilm 
produced in vitro was natural log transformed to fit a normal distribution. We 
conducted 4 linear models with amount of biofilm produced as the response term. 
To test how biofilm formation evolved over the course of the epidemic, we fitted 
year of pathogen isolate sampling as the explanatory term. To test for 
associations between biofilm formation and virulence, we included either peak 
conjunctival swelling or putative host mortality as the explanatory term. Finally, 
we tested the association between biofilm formation and pathogen load by fitting 
peak pathogen load as the explanatory term. 
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Fig. 4. Variation in biofilm abundance between biological replicates of M. 
gallisepticum isolates used in this experiment. Variation in biofilm abundance was 
more pronounced for some isolates than others, and this variation is likely an 
important aspect of M. gallisepticum biofilm formation, possibly arising due to 
stochastic differences in growth and expression causing population stratification 
from growth of polyclonal isolates in culture. 
  
 
 
 
 
 
 
 
 
 
 
Isolate 
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Chapter 4: Positive association between virulence and transmission rate in 
an emerging bacterial pathogen 
 
Abstract 
 
The virulence-transmission trade-off hypothesis posits that for pathogenic 
microbes, the rate of transmission from host-to-host should exist in an equilibrium 
state with the degree of virulence manifested by the pathogen upon the host. 
Under this framework it is assumed that virulence is a function of transmissibility, 
insofar as its evolutionary function is to cause host exploitation and dysregulation 
sufficient for an infecting parasite population to reach transmissible levels and to 
open a successful physiological route for this transmission to occur. In this 
experiment, we utilise observational data and samples collected from a large 
scale in vivo transmission experiment to determine whether virulence and 
transmission are so linked in the Mycoplasma gallisepticum – House finch host-
pathogen model system. We inoculated 59 birds from a susceptible population 
with no prior M. gallisepticum exposure with low-passage isolates collected 
across the epizootic. Each of these inoculated birds was then housed with an 
uninfected sentinel. Time of transmission for each isolate was determined by 
PCR detection of M. gallisepticum in the sentinel from samples taken throughout 
the experiment. Our data shows that transmission rates have evolved over the 
course of the epizootic to be more rapid, with later isolates transmitting to 
secondary hosts faster than isolates sampled early in the epizootic. We then 
show that this increased transmission rate is explained by the increasing 
virulence of isolates across the same time-frame, supporting the assumed 
linkage of virulence and transmission in the trade-off hypothesis. 
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Introduction 
 
The evolution of host resistance to infection should give rise to strong selection 
pressures that shape the evolutionary trajectory of the pathogen. The hypothesis 
that links host resistance and pathogen evolution is the virulence-transmission 
trade-off hypothesis (Alizon et al, 2009; Anderson & May, 1982; Ewald, 1983; 
Gandon et al, 2001). Under this hypothesis, increasing host resistance as a result 
of immune clearance is predicted to select for increasing rates of host exploitation 
and damage (i.e. virulence (Fraser et al, 2007; Ebert, 1998; Mackinnon & Read, 
1999b; Frank, 1996)), which enable the pathogen to transmit to other hosts 
before being cleared (Porco et al, 2005; Gandon & Michalakis, 2000). Since 
greater damages reduce infection duration by hastening host death, this 
hypothesis therefore predicts a negative association between infection duration 
and transmission rate (hence the ‘trade-off’), but a positive association between 
pathogen virulence and transmission rate (Agnew & Koella 1997; Ferguson & 
Read 2002; Mackinnon et al, 2002; Mackinnon et al, 2008; Mackinnon & Read 
1999a, 2003; Paul et al, 2004; Salvaudon et al, 2005; Wickham et al, 2007), with 
host resistance driving the evolution of increasing virulence and transmission 
rate. While the virulence-transmission trade-off hypothesis is increasingly proving 
to be a powerful framework for predicting pathogen evolution (Alizon et al, 2009; 
Alizon & Michalakis 2015; Kerr et al, 2017), we still lack experimental tests of the 
impacts of host resistance on the relationship between virulence and 
transmission rates (Barclay et al. 2012; Mackinnon and Read 2004). 
Evidence for a link between virulence and transmission have, nevertheless, 
been found in a variety of systems (Ferguson et al, 2003; Jensen et al, 2006; 
Mackinnon & Read 1999a, 2003; Mackinnon et al, 2008; Wickham et al, 2007; 
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Agnew & Koella 1997; Paul et al, 2004; Salvaudon et al, 2005), even though the 
precise shape of this association remains unclear. For instance, an experimental 
infection of monarch butterflies (Danaus plexippus) with three clones of the 
protozoan parasite Ophryocystis elektroscirrha found that higher parasite burden 
led to greater host mortality and mating success (i.e. virulence) (de Roode et al, 
2008). Among the infected females that did reproduce, however, higher maternal 
parasite load resulted in a greater deposition of parasites on eggs and plant 
leaves, thus suggesting a positive (and linear) association between levels of 
virulence and transmission. Similarly, a study of HIV-infected patients found that 
the duration of the asymptomatic phase decreased with increasing viral load, and 
that there was a positive association between viral load and transmission 
potential, estimated as the expected number of individuals infected over the 
entire infectious period (Fraser et al, 2007). In this case, however, transmission 
potential reached maximal levels for intermediate levels of viral load, suggesting 
a positive (but non-linear) association between virulence and transmission. 
Whether virulence and transmission rate remain positively associated in the face 
of increasing host resistance, however, remain to be tested. 
  The epidemic of the bacterial pathogen, Mycoplasma gallisepticum, in house 
finches (Haemorhous mexicanus) offers a rare opportunity to test how the 
association between pathogen virulence and transmission rate have evolved in 
response to the spread of host resistance. M. gallisepticum emerged naturally in 
eastern North American house finches after a single host shift from poultry, which 
gave rise to a severe conjunctivitis outbreak that killed millions (Delaney et al, 
2012; Dhondt et al, 1998). Faced with the intensity of this selection event (Gates 
et al. 2018), disease-exposed house finch populations evolved genetic resistance 
in less than 12 years (Bonneaud et al. 2011). The evolution of host resistance, in 
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turn, gave rise to an adaptive increase in pathogen virulence, with pathogen 
fitness increasing significantly as the pathogen was sampled progressively later 
in the epidemic relative to the host (Bonneaud et al. 2018; Tardy et al, 2019).  
Here, we inoculated 55 distinct M. gallisepticum isolates collected from 
epidemic outbreak, throughout the initial spread of host resistance and afterwards 
to present day (1994-2015) into non-resistant houses finches from disease 
unexposed populations. We have shown previously that isolates sampled later in 
the epidemic gave rise to increased conjunctival swelling and putative host 
mortality than isolates obtained earlier (Tardy et al, 2019).  In this study, we 
measured transmission rate to uninfected sentinels from unexposed populations. 
Using wild finches from non-resistant populations allows us to test for genetically-
determined changes in pathogen virulence and transmission rate without the 
confounding effects of protective immune activity (Barclay et al, 2012; Kerr et al, 
2017; Mackinnon & Read, 2004). Evolutionary inferences can be made about the 
pathogen because the 55 bacterial isolates used were collected at random from 
naturally-infected finches and had exhibited variation in symptom severity in 
infected birds, therefore composing a representative sample library of the isolates 
circulating during the epidemic (Bonneaud et al, 2018). In addition, using a large 
number of such isolates obtained across the epidemic protects against the effect 
of outlying isolates and allows for a test of the precise way in which pathogen 
traits have changed over time in response to host resistance. Our approach 
therefore produces a novel test of: i) how pathogen transmission rate has 
changed over the course of a naturally-evolving epidemic; and ii) the association 
between pathogen virulence and transmission rate in the face of increasing host 
resistance.  
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Results 
 
Transmission to the uninfected sentinel by the end of the experiment 35 days 
post-inoculation (dpi) occurred in 76% of trials (N = 45). The rate of transmission 
was measured as 1 divided by the number of days to the transmission event. We 
found a significant effect of year of pathogen sampling on transmission rate, with 
isolates sampled later in the epidemic transmitting faster to uninfected sentinels 
than those sampled earlier (linear model: estimate  se = 0.035   0.012, F1,43 = 
2.93, p = 0.005; Fig. 1). As predicted by the virulence-transmission trade-off 
hypothesis, we found a positive association between the severity of conjunctival 
swelling and transmission rate (linear model: estimate  se = 0.011   0.004, F1,42 
= 2.60, p = 0.013; Fig. 2). Thus, isolates that were more virulent (i.e. caused 
greater conjunctival swelling) also transmitted faster. Furthermore, there was a 
significant difference in transmission rates between isolates that caused or not 
conjunctival swelling severity that, in the wild, would lead to death (linear model: 
estimate  se = 0.040   0.16, F1,43 = 2.54, p = 0.015; Fig. 3). Indeed, isolates that 
caused putative host mortality also transmitted faster than those that did not. 
However, when considering only those isolates that caused putative mortality, we 
did not find the expected negative association between mortality and 
transmission rate. In fact, isolates that killed their primary host faster transmitted 
more slowly than isolates that took longer to kill their host (linear model: estimate 
 se = 0.027   0.022, F1,19 = 2.51, p = 0.021). Nevertheless, this effect 
disappeared when we considered only those isolates that transmitted to sentinels 
before causing putative mortality in their primary host (linear model: estimate  
se = 0.0039   0.0019, F1,16 = 2.08, p = 0.054). In other words, while isolates that 
caused putative mortality in the primary host did transmit faster than those that 
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did not, we found no evidence that mortality rate in the former group was 
associated with greater transmission rates. Concerning degree of conjunctival 
swelling at time of transmission, we calculated a mean swelling of 26.02 mm2 
with a SD error of +/- 9.31 mm2. 
 
 
Figure 1. Changes in transmission rate over the course of the epidemic. We show 
changes in transmission rate from experimentally-inoculated host to uninfected 
sentinel as pathogen isolates were sampled progressively later in the epidemic. 
Points represent raw values; the line is predicted from the model with the 
standard error represented by the ribbon.  
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Figure 2. Association between transmission rate and conjunctival swelling. We 
show transmission rates to an uninfected sentinel house finch as a function of 
mean conjunctival swelling (in pixels), with faster transmission (i.e. lower 
transmission rate) being associated with greater virulence. Points represent raw 
values; the line is predicted from the model with the standard error represented 
by the ribbon. 
 
Figure 3. Association between transmission rate and host mortality. Boxplot 
diagram showing transmission rates to uninfected sentinel house finch for 
isolates that have caused versus have not scored virulence equating to putative 
host mortality. Depicted are the median and range transmission rates; points 
represent raw values. 
 
Discussion 
 
By conducting a natural transmission experiment using a large number of isolates 
of bacterial pathogen, M. gallisepticum, sampled from epidemic outbreak (1994-
5) and over the course of the subsequent 20 years (to 2015), we showed that 
pathogen transmission rate decreased over time, indicating that the pathogen 
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evolved to transmit faster. Furthermore, we found positive associations between 
two measures of virulence (eye swelling and putative mortality) and transmission 
rate. Indeed, isolates that caused more severe conjunctival swelling or putative 
host mortality were those that transmitted fastest. Our result therefore indicate 
that, in this system, pathogen virulence and transmission rate are positively 
associated and that both have increased in response to the spread of host 
resistance.  
Few studies have tested the link between virulence and transmission rate 
directly and even fewer have used direct measures of transmission rate. For 
instance, in the rodent malaria parasite, Plasmodium chabaudi, genetic 
relationships between virulence and transmission were investigated by testing 
the association between virulence and replication rate (as measured 
parasitaemia) and between transmission and replication rate. Furthermore, in this 
experiment transmission was measured as either the density of sexual forms 
(gametocytes) in the blood or the proportion of mosquitoes infected after taking 
a blood-meal from the mouse (Mackinnon & Read, 1999a). Such indirect 
measures, however assume a close causal association with the actual trait, and 
therefore also make inferences about the underlying mechanisms of that trait. As 
a result, whether virulence and transmission are necessarily positively linked 
remains to be tested more broadly. 
In this study, we have found further evidence to support the basic underlying 
assumption of the trade-off hypothesis that transmission and virulence are 
fundamentally linked, with the former being at least in part determined by the 
latter. In addition, we consider that our experiment here has a notable limitation 
in that transmission was measured only from an infected individual to a single 
sentinel in each cage, with the possibility that more significant host-heterogenicity 
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and variation in sentinel susceptibility than expected might skew our results. The 
alternative design, however, of having multiple sentinels per cage would, despite 
the potentially greater accuracy also convolute the experiment in that it would be 
hard to discern transmission from primary (inoculated) to secondary (sentinel) 
versus from secondary to secondary hosts. 
Despite supporting the overall assumption of a functional link between 
virulence and transmission posited by the trade-hypothesis, we do not address 
here the underlying mechanistic cause of this linkage; although increased fomite 
deposition resulting from the increased conjunctival swelling in high virulence 
infections seems the obvious underlying cause this remains to be thoroughly 
tested. A previous study showed that M. gallisepticum fomites could be a major 
source of transmission, but remained viable on inorganic surfaces for less than 
24 hours (Dhondt et al, 2007). A future experiment could attempt to quantify 
viable M. gallisepticum isolates of varying virulence in such fomite depositions 
and test their environmental persistence to discover if selection on either of these 
traits underlies the relationship between transmission and virulence observed 
here. Alternatively, this relationship might be explained by a decrease in the 
infective dose for more virulent isolates, i.e. do more virulent isolates transmit at 
a lower threshold? Although the former experiment will be difficult to address, we 
anticipate that determining the infective dose during each of our transmission 
events recorded in this experiment should be quite simple, applying our qPCR 
method (outlined in Chapter one) to sentinel samples collected on the day of 
transmission as determined here.  
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Methods 
 
Capture and housing 
Wild house finches from populations that have never been exposed to M. 
gallisepticum (i.e. that have not evolved genetic resistance) were captured in 
variety of urban and suburban sites in Arizona, in the summer 2015 (N = 118, 64 
males and 54 females). M. gallisepticum has never been recorded in the sampling 
area despite continuous monitoring (Staley et al, 2018). Using birds that have not 
had the opportunity to evolve protective immune responses to M. gallisepticum is 
essential to measuring virulence and transmission rate without the confounds of 
the capacity for immune clearance (Kerr et al, 2017). Birds that had hatched in 
the spring 2015 were trapped, weighed and banded with a numbered metal tag 
for individual identification. They were then immediately transported by car to 
indoor aviaries at Arizona State University’s Tempe campus, where they were 
housed for the remainder of the experiment. On arrival, we obtained a blood 
sample from all birds using brachial venipuncture (60 μL of whole blood) and a 
choanal swab. A lack of prior infection with M. gallisepticum since hatching was 
confirmed by screening blood plasma for anti-M. gallisepticum antibodies using 
a serum plate agglutination assay (Luttrell et al, 1996), and a lack of current 
infection was verified using the choanal swabs in PCR amplification of M. 
gallisepticum DNA (Roberts et al, 2001). Although none of the birds displayed 
any sign of infection with other diseases, all birds were prophylactically medicated 
for infection with Trichomonas gallinae with carnidazole (Spartrix, 
Janssen/Elanco) and Isospora spp with sulfadimethoxine over 40 days. The birds 
were then allowed to acclimate for one month prior to experimental onset and 
provided with ad libitum food and water throughout.  
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Experimental inoculation and transmission rate 
The birds were divided into 2 groups of 59 birds. Each of the 55 M. gallisepticum 
isolates sampled over the course of the epidemic was inoculated into one bird 
selected at random from the 59 birds of the first group (30 males and 29 females), 
with 5 isolates (one from 1994, two from 1995, and two from 2007) each 
inoculated in two birds. Isolates were originally obtained from naturally infected, 
wild-caught house finches by swabbing the conjunctiva of a symptomatic bird and 
placing the swab in SP4 growth medium. Isolates were collected over a 20 year-
period and obtained from various urban and suburban sites in 8 different States 
in the eastern US (mainly from Alabama). Isolates were administered via 20 μL 
of culture containing 1 × 104 to 1 × 106 colour changing units/mL of M. 
gallisepticum in both eyes. Following inoculation, all 59 birds were maintained in 
separate cages and co-housed with one bird from the second group in 54 
randomly-assigned female-male pairs and 5 male-male pairs. Birds from the 
second group thus served as an uninfected sentinel. Transmission rate to the 
sentinel was measured by amplification of M. gallisepticum DNA from 
conjunctival and tracheal swabs (Roberts et al, 2001) obtained at 2, 3, 4, 5, 6, 7, 
8, 11, 14, 17, 20, 23, 26, 29, 32 and 35 days post-inoculation (dpi). All birds had 
access to ad libitum food and water throughout the duration of the experiment. 
The experiment was stopped at 35 dpi and all birds were euthanized as stipulated 
by home office licencing. Protocols were approved by Institutional Animal Care 
and Use Committees (IACUC) of Auburn University (permit # PRN 2015-2721) 
and of Arizona State University (permit #15-1438R), as well as by Institutional 
Biological Use Authorizations to Auburn University (# BUA 500), and the 
University of Exeter’s ethics committee.  
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Virulence 
To quantify the size of the conjunctiva and so severity of conjunctival swelling, 
we photographed the right and left eyes at 0, 6, 13 and 25 days post-inoculation 
(dpi) from a standardized distance. We then measured the average area of the 
conjunctiva swelling across the two eyes and at each day as: the area of the outer 
ring minus the area of the inner ring at 6, 13 or 25 dpi - the area of the outer ring 
minus the area of the inner ring at 0 dpi (Staley et al, 2018). Measurements of 
photographs were done blindly with respect to the isolate inoculated. Weighted 
averages of conjunctival swelling at time of transmission were calculated using 
quantitative conjunctival swelling data as above, where swelling on day of 
transmission was calculated from the linear interpolation of its two nearest data-
points (e.g. swelling at 11 dpi interpolated from linear change between 6 dpi. and 
13 dpi).   
 Finally, eyes were also inspected visually on days 3, 6, 8, 14, 21, 25, 28 and 34 
post-infection: infection is considered lethal when the conjunctiva is red to purple, 
and the eye is difficult to see and produces discharge – such symptoms, with little 
or no vision possible, are thought to have caused the death of millions of infected 
finches due to starvation or predation (Adelman et al, 2017; Kollias et al, 2004; 
Roberts et al, 2001).  
 
Statistical analyses 
All statistical analyses were conducted in R 3.3.2 (Team 2016) and figures were 
made using ggplot2 (Wickham, 2009). In all analyses, transmission rate was 
natural log transformed to fit a normal distribution. We analysed changes in 
transmission rate over time using a linear model with transmission rate (log) as 
the response term and with year of pathogen sampling as the explanatory term. 
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Associations between transmission rate and virulence were analysed similarly 
with transmission rate (log) as the response term and with either quantitative 
measures of conjunctival swelling or putative host mortality as the explanatory 
term. Finally, for those isolates that caused putative host mortality, we tested the 
association between infection duration in the primary host and transmission rate 
to secondary host using a linear model with transmission rate (log) as the 
response term and days to putative mortality as the explanatory term. 
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Appendix 1 
 
Models examining the associations between bacterial load, replication rate and 
transmission rates are presented here (see Bonneaud, C., Tardy, L., Hill, G. E., 
McGraw, K. J., Wilson, A., Giraudeau, M., Experimental evidence for stabilizing 
selection on pathogen virulence, in review). 
 
 Methods and Results 
 
Associations were measured using linear models with log transmission rate as 
the response term against explanatory terms of peak pathogen load, total 
pathogen load (the integral of peak pathogen load over the 34 day experiment), 
and replication rate (Peak pathogen load / days to peak pathogen load, see 
Chapter. 2). 
Our results suggest no association between pathogen and transmission rate 
using either peak bacterial load or its integral over the experiment as 
explanatory variables (Peak pathogen load coef = 0.88e-4 +/- 0.41e-3, F1, 41 = 
0.22, p = 0.82, Total pathogen load coef = 0.60e-5 +/- 0.58e-4, F1, 41 =0.1, P = 
0.92). Similarly, no association between replication rate and transmission was 
found in these data (Replication rate coef = 0.20e-2 +/- 0.87e-2, F1, 43, = 0.24, p = 
0.82) 
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Fig. 1. Association between transmission rate and pathogen load. (A) 
Transmission rate as a function of pathogen load. (B) Transmission rate as a 
function of pathogen replication rate. Points represent raw data. 
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Chapter 5: Effect of resistance on pathogen transmission rate and virulence 
in secondary hosts 
 
Abstract 
 
Under the trade-off hypothesis we expect that host-resistance should select for 
higher virulence pathogens over time, as increased clearance should weed out 
those pathogen lineages which fail to reach transmissible levels at a sufficient 
rate. The result of this is that in vivo passage of an infectious pathogen in a 
resistant host will result in higher virulence lineages being transmitted 
preferentially onwards into new hosts, biasing the pathogen population in such 
secondary towards more virulent and faster transmitting lineages. In this 
experiment, we utilise samples from a large-scale experimental infection study in 
which the transmission rates of various Mycoplasma gallisepticum isolates and 
their virulence in primary and secondary hosts was measured. Birds from both 
susceptible (unexposed) and resistant (exposed) populations were inoculated 
with M. gallisepticum isolates from across the epizootic and housed alongside 
susceptible sentinel birds. Transmission rates and probabilities were determined 
by PCR detection of M. gallisepticum in these secondary (sentinel) birds from 
regularly taken samples during the experiment. Isolate virulence in these 
secondary hosts was also determined by measures of peak conjunctival swelling 
in the sentinels. Our results suggest that a single passage in a resistant versus 
naive primary host does not have a significant differential effect on either the 
probability of transmission occurring or on the virulence manifest by M. 
gallisepticum in a secondary infection in a susceptible host, indicating that the 
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selective effects of resistance on pathogen evolution may not be evident within a 
single infection.  
 
Introduction 
 
Host resistance to infectious diseases can have profound effects on pathogen 
evolution. Theoretical models predict that pathogens will maximise their success 
by maximising the number of secondary hosts that they infect over the time span 
of an infection. Because faster transmission to secondary hosts comes at the cost 
of greater exploitation rate of the primary host, which accelerates host death (i.e. 
virulence), pathogens should evolve a level of virulence that optimises the trade-
off between infection duration and transmission rate. By clearing the pathogen, 
host immune activity will thus reduce the infectious period, thereby favouring 
pathogens that are able to transmit faster and are hence more virulent. While 
there is some experimental support for an effect of host resistance on pathogen 
virulence evolution, the speed at which resistance selects for increased virulence 
remains unknown. In particular, whether the infection of a primary host that is 
resistant is sufficient to increase pathogen virulence in secondary infections 
remains to be tested. 
The impact of the level of resistance of the primary host on the virulence of 
secondary infections has been measured in the context of ‘leaky’ vaccines. 
Vaccines are considered leaky when they prevent host death from infection 
without preventing pathogen establishment, replication or transmission. Indeed, 
such vaccines will alleviate the mortality costs of high virulence, thus allowing 
increased virulence to evolve unchecked.  For example, when chickens that were 
either unvaccinated or vaccinated with a leaky vaccine, were inoculated with 
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highly lethal strains of Marek’s Disease Virus (MDV), transmission to an 
uninfected sentinel occurred successfully in the latter group only, with all the 
unvaccinated chickens dying before transmission (Read et al 2015). 
Furthermore, vaccination was found to have increased the transmission rate of a 
slightly less virulent strain of MDV. Together these results suggest that 
vaccination can allow the transmission of pathogens that would normally be too 
lethal to transmit, and that resistance can have a selective impact on pathogen 
virulence in the course of a single infection. Whether this finding is generalisable, 
in particular in the context of natural host responses to infection, remains to be 
determined. 
  The epidemic of the bacterial pathogen, Mycoplasma gallisepticum, in house 
finches (Haemorhous mexicanus) allows us to test the selective impact of host 
resistance over the course of single primary infection on the level of pathogen 
virulence during a secondary infection. M. gallisepticum emerged naturally in 
eastern North American house finches after a single host shift from poultry, which 
gave rise to a severe conjunctivitis outbreak that killed millions (Delaney et al. 
2012; Dhondt et al, 1998). This intense selection event led to the evolution of 
resistance in disease-exposed house finch populations in less than 12 years 
(Gates et al. 2018; Bonneaud et al. 2011). The evolution of host resistance was 
found to have given rise, in turn, to an adaptive increase in pathogen virulence, 
with pathogen fitness increasing significantly as the pathogen was sampled 
progressively later in the epidemic relative to the host ((Bonneaud et al. 2018), 
Tardy et al).  
Here, we inoculated 55 distinct M. gallisepticum isolates collected from 
epidemic outbreak, throughout the initial spread of host resistance and afterwards 
to present day (1994-2015) into resistant houses finches from disease- exposed 
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populations and into non-resistant (susceptible) ones from disease-unexposed 
populations. Each isolate was inoculated into at least one resistant and one 
susceptible house finch, and each experimentally inoculated finch was separately 
co-housed with one uninfected sentinel originated from unexposed populations. 
Using non-resistant sentinels allows us to test for changes in pathogen virulence 
and transmission rate without the confounding effects of protective immune 
activity (Barclay et al. 2012; Kerr et al. 2017; Mackinnon & Read 2004). 
Furthermore, using a large number of isolates obtained across the epidemic and 
of differing level of virulence (Bonneaud et al, 2018) protects against the effect of 
outlying isolates and allows test of the precise way in which pathogen traits have 
changed in response to the level of resistance of the primary host. Thus, our 
approach allows a novel test of the impact of variation in resistance in the primary 
host on: (i) pathogen transmission rate to secondary hosts; and (ii) the level of 
pathogen virulence in secondary hosts. 
 
Results 
 
First, we tested the effect of the level of resistance of the primary host on the 
pathogen’s transmission rate to secondary host. The time to transmission from 
experimentally-infected primary hosts to uninfected sentinels varied between 2 
and 23 days, with an average of 7 days. We found no effect of the level of 
resistance of the primary host on the time to transmission to secondary hosts 
(estimate  se = -0.06  0.12, χ2 = 0.28, df = 1, p = 0.60). Second, we tested the 
effect of the level of resistance of the primary host on the pathogen’s virulence in 
secondary host. Peak symptom severity in sentinel birds followed a zero-inflated 
distribution, with 27% (30/112) of inoculated finches remaining asymptomatic. 
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Consequently, we analysed peak symptoms using a 2-part hurdle model (Zuur & 
Ieno 2016). The first part tested whether the level of resistance of primary hosts 
had differential effects on the probability of the infection in secondary hosts 
overall. However, we found no evidence for an effect of the level of resistance of 
the primary host on the probability of that secondary hosts developed 
conjunctivitis (Figure 1A; 1st part of hurdle model: mixed effect logistic regression, 
estimate  se = 1.2  1.1, z = 1.06, p = 0.29). The second part of the model then 
tested for differences in the severity of the infection in secondary hosts that were 
symptomatic. We found only a non-significant marginal effect of the level of 
resistance of the primary host on the peak clinical severity of symptomatic 
secondary hosts, with peak severity increasing following infection of resistant 
primary hosts (Figure 1B; 2nd part of hurdle model: linear mixed effect model, 
estimate  se = 0.17  0.09, χ2 = 3.4, df = 1, p = 0.067).  
Tests of the symptom severity and resistance/tolerance to infection between 
Arizona and Alabama populations was investigated in Bonneaud et al, 2018. 
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Figure 1. Symptom severity of sentinel. (A) We show the probability that the 
secondary host develops clinical symptoms of conjunctival swelling as a function 
of the level of resistance of the primary host. Grey points represent raw values; 
the larger blacks are predicted from the model. Grey points offset from actual for 
clarity of image. (B) Boxplot diagram showing the conjunctival swelling score in 
secondary host as a function of the level of resistance of the primary host. 
Depicted are the median and range symptoms score; points represent raw 
values.  
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Discussion 
 
That we observed no significant different in either the probability of transmission 
or the peak virulence manifested in sentinels attributable to primary (inoculated) 
host resistance is perhaps not overly surprising given the complexity of the 
potential underlying mechanisms of these traits. The most parsimonious 
explanation for this null result is that simply one in vivo passage is insufficient for 
detectible differences in pathogen virulence in response to either the presence or 
absence of host resistance to emerge. Studies which have looked at the effect of 
limited in vitro versus in vivo passages on pathogen virulence, roughly 
approximating a non-resistant versus resistant environments have returned 
mixed findings. Salmonella enterica serovar Typhimurium virulence has been 
shown to increase in secondary infections following single passaging in mice, 
whilst decreasing in subsequent in vitro passaging (Mastroeni et al, 2011), whilst 
for Mycobacterium tuberculosis passaged in mice and guinea pigs no such 
increase in virulence over limited time-scales was observed (Converse et al, 
2010).  
Alternatively, we might construe the lack of expected increases in 
transmission probability and virulence for isolates passaged in resistant hosts to 
be linked phenomena, suggesting a trade-off in virulence, it’s underlying 
mechanisms and transmissibility and infectivity. Our previous work has 
suggested that as host-resistance has increased over the epizootic, M. 
gallisepticum has evolved increased virulence and replication rates (Chapter 2), 
and the rate at which it transmits to secondary hosts (Chapter 4). M. gallisepticum 
also appears to be losing the ability to form biofilms over time in response to host 
resistance, potentially as a mechanism to maintain and increase its virulence 
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(Chapter 3). With this in mind, it may be that our lack of significant findings in this 
single-passage experiment reflect a scenario in which, although the rate at which 
transmission occurs will increase by selection in the resistant host, the infectivity 
of these more virulent lineages is somehow reduced. Principally, a lack of ability 
for more virulent isolates to produce biofilms may be reducing their rate of 
successfully establishing an infection, with lineages within a transmitted 
population which might express lower virulence but more colonisation factors (i.e. 
biofilm) being more successful on encountering the secondary host. The 
immunoevasive properties of biofilm formation have been studied in a number of 
host-pathogen systems, and some innate and cell-mediated host-immune 
processes are known to be inhibited by pathogens which readily form biofilm 
(Rolides et al, 2015); ergo we might posit that the lack of ability to form biofilms 
makes these more virulent lineages of M. gallisepticum in our experiment more 
likely to be detected and controlled or cleared by the early immune-responses of 
the secondary hosts. In the future, it might be possible to sequence the 
metagenome of our transmitted M. gallisepticum at the before, at the point of 
initial transmission, and then later within the secondary host, thereby unravelling 
the population genetics of what might be occurring at this transmission 
bottleneck. 
 
Methods 
 
Capture and housing 
Wild house finches from populations that have never been exposed to M. 
gallisepticum (i.e. that have not evolved genetic resistance) were captured in 
variety of urban and suburban sites in Arizona, in the summer 2015 (N = 118, 64 
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males and 54 females). M. gallisepticum has never been recorded in the sampling 
area despite continuous monitoring (Staley et al, 2018). Using birds that have not 
had the opportunity to evolve protective immune responses to M. gallisepticum is 
essential to measuring virulence and transmission rate without the confounds of 
the capacity for immune clearance (Kerr et al. 2017). Birds that had hatched in 
the spring 2015 were trapped, weighed and banded with a numbered metal tag 
for individual identification. 
They were then immediately transported by car to indoor aviaries at Arizona State 
University’s Tempe campus, where they were housed for the remainder of the 
experiment. On arrival, we obtained a blood sample from all birds using brachial 
venipuncture (60 μL of whole blood) and a choanal swab. A lack of prior infection 
with M. gallisepticum since hatching was confirmed by screening blood plasma 
for anti-M. gallisepticum antibodies using a serum plate agglutination assay 
(Luttrell et al. 1996), and a lack of current infection was verified using the choanal 
swabs in PCR amplification of M. gallisepticum DNA (Roberts et al. 2001). 
Concurrently, during the summer of 2015, wild house finches from adapted 
populations where Mycoplasma gallisepticum has circulated from the outset of 
the epizootic, were captured in urban and suburban parts of Alabama. They were 
similarly screened for current or prior Mycoplasma gallisepticum infection via 
serum plate agglutination and PCR assays (Luttrell et al, 1996; Roberts et al, 
2001), and birds testing positive for either current or prior infection were released 
immedietly. The remainder (N = 53; 24 males and 29 females) were transported 
to and housed seperately to those collected from unexposed Arizona populations 
at the indoor aviary facilities of Arizona State University. Although none of the 
birds displayed any sign of infection with other diseases, all birds were 
prophylactically medicated for infection with Trichomonas gallinae with 
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carnidazole (Spartrix, Janssen/Elanco) and Isospora spp with sulfadimethoxine 
over 40 days, following which birds from both populations were allowed to 
acclimate for one month prior to experimental onset and provided with ad libitum 
food and water throughout.  
 
Experimental inoculation and transmission rate 
Birds were then assigned to groups so that all 53 birds from the resistant Alabama 
population would be housed with one bird from the unexposed Arizona 
population, making (N = 53) randomly assigned male-female pairings. The 
remaining 118 unexposed population finches were then divided into experimental 
and sentinel male-female pairs and 5 male-male pairs (total N = 59) 
 One of 55 M. gallisepticum isolates sampled over the course of the epidemic 
was inoculated into one bird selected at random from both groups. In the 
unexposed-unexposed paired group containing 59 birds (30 males and 29 
females), 5 isolates (one from 1994, two from 1995, and two from 2007) were 
each inoculated in two birds. All 53 Alabama-caught resistant birds from the 
resistant-unexposed paired group were similarly inoculated with one of the 55 
isolates selected at random. 
 Isolates were originally obtained from naturally infected, wild-caught house 
finches by swabbing the conjunctiva of a symptomatic bird and placing the swab 
in SP4 growth medium. Isolates were collected over a 20 year-period and 
obtained from various urban and suburban sites in 8 different States in the 
eastern US (mainly from Alabama). Isolates were administered via 20 μl of culture 
containing 1 × 104 to 1 × 106 colour changing units/mL of M. gallisepticum in both 
eyes. Following inoculation, all 59 birds were maintained in separate cages and 
co-housed with one bird from the second group in 54 randomly-assigned female-
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male pairs and 5 male-male pairs. Birds from the second group thus served as 
an uninfected sentinel. Transmission rate to the sentinel was measured by 
amplification of M. gallisepticum DNA from conjunctival and tracheal swabs 
(Roberts et al, 2001) obtained at 2, 3, 4, 5, 6, 7, 8, 11, 14, 17, 20, 23, 26, 29, 32 
and 35 days post-inoculation (dpi). All birds had access to ad libitum food and 
water throughout the duration of the experiment. The experiment was stopped at 
35 dpi and all birds were euthanized as stipulated by home office licencing. 
Protocols were approved by Institutional Animal Care and Use Committees 
(IACUC) of Auburn University (permit # PRN 2015-2721) and of Arizona State 
University (permit #15-1438R), as well as by Institutional Biological Use 
Authorizations to Auburn University (# BUA 500), and the University of Exeter’s 
ethics committee.  
 
Virulence 
To quantify the size of the conjunctiva and so severity of conjunctival swelling, 
we photographed the right and left eyes at 0, 6, 13 and 25 days post-inoculation 
(dpi) from a standardized distance. We then measured the average area of the 
conjunctiva swelling across the two eyes and at each day as: the area of the outer 
ring minus the area of the inner ring at 6, 13 or 25 dpi - the area of the outer ring 
minus the area of the inner ring at 0 dpi (Staley et al, 2018). Measurements of 
photographs were done blindly with respect to the isolate inoculated. Finally, eyes 
were also inspected visually on days 3, 6, 8, 14, 21, 25, 28 and 34 post-infection: 
infection is considered lethal when the conjunctiva is red to purple, and the eye 
is difficult to see and produces discharge – such symptoms, with little or no vision 
possible, are thought to have caused the death of millions of infected finches due 
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to starvation or predation (Adelman et al, 2017; Kollias et al, 2004; Roberts et al, 
2001).  
 
Statistical analyses 
All statistical analyses were conducted in R 3.3.2 (Team 2016) and figures were 
made using ggplot2 (Wickham, 2009). Transmission rate was natural log (ln) 
transformed to fit a normal distribution. We analysed the effect of the level of 
resistance of the primary host on transmission rates to secondary hosts using a 
linear mixed model with transmission rate (ln) as the response term, with the level 
of resistance of the primary host (resistant versus non-resistant) as the 
explanatory term, and with isolate identity as the random term. Peak symptoms 
in secondary hosts followed a zero-altered gamma distribution (ZAG) and was 
therefore analysed using 2-parts hurdle model (Zuur & Ieno 2016). Part 1 used a 
mixed effect logistic regression with a logit link function on whether the secondary 
host failed or not to developed symptoms; part 2 used a linear mixed effect model 
with gamma error structure and log link function on the values of symptoms 
scores > 0 (Zuur & Ieno 2016). In both steps, symptoms score was fitted as the 
response term (score = 0 versus score >0 in the former; scores > 0 values in the 
latter), the level of resistance of the primary host (resistant versus non-resistant) 
was fitted as the explanatory term, and pathogen isolate identity as a random 
effect. 
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Concluding statement 
 
The work conducted under this project and presented above has, by employing 
an integrative molecular microbiology approach furthered both our understanding 
of the co-evolution of M. gallisepticum and its novel host in the house finch, and 
more generally has provided a system in which to test some key assumptions of 
the virulence-transmission trade-off hypothesis. We find strong support for many 
of the key underlying assumptions of the trade-off hypothesis, including the 
predicted linkage between virulence and transmission (Chapter 4) and the 
increase in pathogen virulence in response to emerging host-resistance (Chapter 
1). However, our research also highlights that many of the assumptions we might 
make about the molecular underpinnings of these traits can be often 
oversimplified. An assumption of virulence being driven solely by pathogen 
replication, and of the later being thus a decent proxy for the former, was shown 
in Chapter 1 to hold perhaps for only the early stages of co-evolution in novel 
host-pathogen associations, with selection for increased replication easing off 
after significant host resistance emerges whilst virulence continues to increase.  
In Chapter 2 we investigated whether a complex trait such as biofilm 
formation might contribute to this unexpected observation, indicating as we 
suspected that this dis-linkage between virulence and replication could perhaps 
be due to selection shifting to optimise the immune-manipulative strategies 
employed by Mycoplasmas. That we saw a decrease in biofilm forming capability 
in M. gallisepticum over time was quite opposite to our initial predictions; we 
would have expected that host-resistance might select for enhanced 
immunoevasion and utilising biofilms to produce a protective environment. Our 
finding contrary to this is in interesting one; raising the prospect that we are in 
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fact observing a selection against biofilm formation as a pro-inflammatory  
immunomodulatory strategy, increasing the immuno-visibility of late epizootic M. 
gallisepticum isolates in order to maintain the high virulence needed for optimal 
transmission. 
This observation also helps to contextualise our results in Chapter 5 in 
which we detected no significant increase in either transmission probability or 
virulence in a secondary infection in response to host resistance. Although we 
postulate that the most likely explanation for this is simply that a single passage 
in a resistant host provides insufficient time for selection to generate a 
discernable signal, the secondary explanation mentioned – that the adaptations 
in M. gallisepticum which arise in response to host resistance might have some 
detrimental affects on its ability to initially infect and colonise after transmission, 
also bears further consideration.  
In addressing this, the author considers that future work should focus on 
the molecular biology of M. gallisepticum infection dynamics, particularly 
regarding transmission traits, on a more granular scale. For example breaking 
transmission down into stages of i) escape from the primary host, ii) ability to 
persist as fomites and iii) ability to infect and colonise a secondary host, would 
allow for relatively simple experiments to be designed targeting specific biological 
determinants at each stage. One way to approach this work would certainly be to 
apply a genomic, transcriptomic and gene-expression focused direction of study; 
identifying genes which have accumulated mutations or which are differentially 
expressed under the different conditions found at these more defined stages. We 
are confident that, in addition to its important findings presented in this thesis, this 
project has further helped to lay the groundwork for such future undertakings.  
